JPWO2020005873A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020005873A5 JPWO2020005873A5 JP2020572895A JP2020572895A JPWO2020005873A5 JP WO2020005873 A5 JPWO2020005873 A5 JP WO2020005873A5 JP 2020572895 A JP2020572895 A JP 2020572895A JP 2020572895 A JP2020572895 A JP 2020572895A JP WO2020005873 A5 JPWO2020005873 A5 JP WO2020005873A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridazine
- triazolo
- phenol
- pyrazole
- tetramethylpiperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1,2,5,6-tetrahydropyridinyl Chemical group 0.000 claims 278
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 113
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 38
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 38
- 125000000217 alkyl group Chemical group 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 21
- ZXRCAYWYTOIRQS-UHFFFAOYSA-N hydron;phenol;chloride Chemical compound Cl.OC1=CC=CC=C1 ZXRCAYWYTOIRQS-UHFFFAOYSA-N 0.000 claims 21
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 20
- 125000003545 alkoxy group Chemical group 0.000 claims 16
- 125000000623 heterocyclic group Chemical group 0.000 claims 13
- 125000001424 substituent group Chemical group 0.000 claims 10
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 7
- JELQZSVKOONUKD-UHFFFAOYSA-N phenol dihydrochloride Chemical compound Cl.Cl.OC1=CC=CC=C1.OC1=CC=CC=C1 JELQZSVKOONUKD-UHFFFAOYSA-N 0.000 claims 7
- 125000002619 bicyclic group Chemical group 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 125000002950 monocyclic group Chemical group 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 5
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims 4
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 3
- 125000000033 alkoxyamino group Chemical group 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical group [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 3
- WFJZBOIOPMOUCB-UHFFFAOYSA-N pyridazine;hydrochloride Chemical compound Cl.C1=CC=NN=C1 WFJZBOIOPMOUCB-UHFFFAOYSA-N 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidine Chemical compound CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 claims 2
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 claims 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 2
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- PUBSMDUBHLYMIX-UHFFFAOYSA-N phenol;dihydrochloride Chemical compound Cl.Cl.OC1=CC=CC=C1 PUBSMDUBHLYMIX-UHFFFAOYSA-N 0.000 claims 2
- DNRXKUPYJHTZJE-UHFFFAOYSA-N phenol;hydrobromide Chemical compound Br.OC1=CC=CC=C1 DNRXKUPYJHTZJE-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 1
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims 1
- YOUQXTMNMLEWCM-UHFFFAOYSA-N 2-(1-piperidin-4-ylpyrazolo[3,4-c]pyridazin-5-yl)-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=NN=C2N(N=CC2=C1)C1CCNCC1 YOUQXTMNMLEWCM-UHFFFAOYSA-N 0.000 claims 1
- FVXQGVZLCVMFLE-UHFFFAOYSA-N 2-(1-piperidin-4-ylpyrazolo[3,4-c]pyridazin-5-yl)-5-(1H-pyrazol-4-yl)phenol hydrochloride Chemical compound Cl.Oc1cc(ccc1-c1cc2cnn(C3CCNCC3)c2nn1)-c1cn[nH]c1 FVXQGVZLCVMFLE-UHFFFAOYSA-N 0.000 claims 1
- OLYLBVGBSDAEHV-UHFFFAOYSA-N 2-(1H-pyrazol-4-yl)phenol hydrochloride Chemical compound Cl.Oc1ccccc1-c1cn[nH]c1 OLYLBVGBSDAEHV-UHFFFAOYSA-N 0.000 claims 1
- GDUVBKSVYWFWGV-UHFFFAOYSA-N 2-(1h-pyrazol-4-yl)phenol Chemical compound OC1=CC=CC=C1C1=CNN=C1 GDUVBKSVYWFWGV-UHFFFAOYSA-N 0.000 claims 1
- NJYKXOJRBBASGJ-UHFFFAOYSA-N 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)triazolo[4,5-c]pyridazin-6-yl]-5-(1,2,4-thiadiazol-5-yl)phenol Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=NC=NS1)O)(C)C)C NJYKXOJRBBASGJ-UHFFFAOYSA-N 0.000 claims 1
- QFFQDEGMTBBEMV-UHFFFAOYSA-N 2-methyl-6-[3-(2,2,6,6-tetramethylpiperidin-4-yl)triazolo[4,5-c]pyridazin-6-yl]-1H-benzimidazol-5-ol Chemical compound C1(NC(CC(N2C3=NN=C(C4=C(O)C=C5NC(=NC5=C4)C)C=C3N=N2)C1)(C)C)(C)C QFFQDEGMTBBEMV-UHFFFAOYSA-N 0.000 claims 1
- VTBHBWBXALXSJK-UHFFFAOYSA-N 3-methyl-6-[3-(2,2,6,6-tetramethylpiperidin-4-yl)triazolo[4,5-c]pyridazin-6-yl]benzimidazol-5-ol Chemical compound N1C(CC(CC1(C)C)N1C2=C(N=N1)C=C(C1=C(O)C=C3N(C=NC3=C1)C)N=N2)(C)C VTBHBWBXALXSJK-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- YFWCCAXUEVEWBF-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrazolo[3,4-c]pyridazin-5-yl]phenol Chemical compound CC1(NC(CC(C1)N1C2=C(C=N1)C=C(C1=CC=C(C=3C=NNC=3)C=C1O)N=N2)(C)C)C YFWCCAXUEVEWBF-UHFFFAOYSA-N 0.000 claims 1
- ZEZSKTLJQHOQSU-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[7-(2,2,6,6-tetramethyl-1,3-dihydropyridin-4-yl)thieno[3,2-c]pyridazin-3-yl]phenol Chemical compound N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)C(=CS2)C=1CC(NC(C=1)(C)C)(C)C ZEZSKTLJQHOQSU-UHFFFAOYSA-N 0.000 claims 1
- GIYSUKBTCIPXND-UHFFFAOYSA-N 5-(4-methylpyrazol-1-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)triazolo[4,5-c]pyridazin-6-yl]phenol Chemical compound C1(C)(CC(N2C3=C(N=N2)C=C(C2=C(C=C(N4C=C(C=N4)C)C=C2)O)N=N3)CC(C)(C)N1)C GIYSUKBTCIPXND-UHFFFAOYSA-N 0.000 claims 1
- WLVVXZGHMCKLHT-UHFFFAOYSA-N Br.FC1=CC(=C(C=C1C1=CC=C(C=C1)O)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound Br.FC1=CC(=C(C=C1C1=CC=C(C=C1)O)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C WLVVXZGHMCKLHT-UHFFFAOYSA-N 0.000 claims 1
- PXVVRAVHOUCNOQ-UHFFFAOYSA-N BrC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound BrC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C PXVVRAVHOUCNOQ-UHFFFAOYSA-N 0.000 claims 1
- RMBKEKVHYKCBQU-UHFFFAOYSA-N C(=O)OC1=C(C=CC(=C1)C1=NC=C(C=C1)OC(F)F)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound C(=O)OC1=C(C=CC(=C1)C1=NC=C(C=C1)OC(F)F)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C RMBKEKVHYKCBQU-UHFFFAOYSA-N 0.000 claims 1
- IETUBBFAMCEKDY-UHFFFAOYSA-N C(C)N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound C(C)N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C IETUBBFAMCEKDY-UHFFFAOYSA-N 0.000 claims 1
- XXNQVQXOGYTQAO-UHFFFAOYSA-N C(CC)N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound C(CC)N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C XXNQVQXOGYTQAO-UHFFFAOYSA-N 0.000 claims 1
- WGGHKOLLPVNZPN-VPYROQPTSA-N C(N1N=CC(=C1)C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] Chemical compound C(N1N=CC(=C1)C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] WGGHKOLLPVNZPN-VPYROQPTSA-N 0.000 claims 1
- AASTXZYIDCCVHJ-UHFFFAOYSA-N C1(C)(CC(N2C3=C(C=C2)N=C(C2=CC(F)=C(C4=CNN=C4)C=C2F)C=N3)CC(C)(C)N1)C Chemical compound C1(C)(CC(N2C3=C(C=C2)N=C(C2=CC(F)=C(C4=CNN=C4)C=C2F)C=N3)CC(C)(C)N1)C AASTXZYIDCCVHJ-UHFFFAOYSA-N 0.000 claims 1
- ZMKXJPXWSNQLIU-UHFFFAOYSA-N C1(CC1)N1C(C=C(C=C1)C1=CC(=C(C=C1)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)O)=O Chemical compound C1(CC1)N1C(C=C(C=C1)C1=CC(=C(C=C1)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)O)=O ZMKXJPXWSNQLIU-UHFFFAOYSA-N 0.000 claims 1
- MDLNGIZCASBHMN-UHFFFAOYSA-N C1(NC(CC(C1)N1C2=NN=C(C=C2N=N1)C1=CC=C(C=2C=CNC=2)C=C1O)(C)C)(C)C Chemical compound C1(NC(CC(C1)N1C2=NN=C(C=C2N=N1)C1=CC=C(C=2C=CNC=2)C=C1O)(C)C)(C)C MDLNGIZCASBHMN-UHFFFAOYSA-N 0.000 claims 1
- HGNVKFMIZLRXNG-UHFFFAOYSA-N C1(NC(CC(C2=CSC3=CC(C4=CC=C(C=5C=NNC=5)C=C4O)=NN=C23)C1)(C)C)(C)C Chemical compound C1(NC(CC(C2=CSC3=CC(C4=CC=C(C=5C=NNC=5)C=C4O)=NN=C23)C1)(C)C)(C)C HGNVKFMIZLRXNG-UHFFFAOYSA-N 0.000 claims 1
- DMSDXTCCTHPVTI-UHFFFAOYSA-N C1CN(CCN1)C1=CNC2=C1N=NC(=C2)C1=CC=C(C=2C=NNC=2)C=C1O Chemical compound C1CN(CCN1)C1=CNC2=C1N=NC(=C2)C1=CC=C(C=2C=NNC=2)C=C1O DMSDXTCCTHPVTI-UHFFFAOYSA-N 0.000 claims 1
- CXMDEHRGUNSXHR-UHFFFAOYSA-N C=1N=CN2C=1C=C(C=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound C=1N=CN2C=1C=C(C=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C CXMDEHRGUNSXHR-UHFFFAOYSA-N 0.000 claims 1
- IEZREAUMRJSMTC-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3C=N2)C4=C(C=C(C=C4)C5=CC=NC=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3C=N2)C4=C(C=C(C=C4)C5=CC=NC=C5)O)C.Cl IEZREAUMRJSMTC-UHFFFAOYSA-N 0.000 claims 1
- CJSNRGRIMPZUIK-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3C=N2)C4=C(C=C(C=C4)C5=CN=CC=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3C=N2)C4=C(C=C(C=C4)C5=CN=CC=C5)O)C.Cl CJSNRGRIMPZUIK-UHFFFAOYSA-N 0.000 claims 1
- AWMVRQRPJPJTOJ-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3C=N2)C4=C(C=C(C=C4)C5=CN=CN=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3C=N2)C4=C(C=C(C=C4)C5=CN=CN=C5)O)C.Cl AWMVRQRPJPJTOJ-UHFFFAOYSA-N 0.000 claims 1
- CYRDUAAZDRATQT-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=CN6C=CN=C6N=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=CN6C=CN=C6N=C5)O)C.Cl CYRDUAAZDRATQT-UHFFFAOYSA-N 0.000 claims 1
- HRJAULMCRJPELB-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=CN=NC=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=CN=NC=C5)O)C.Cl HRJAULMCRJPELB-UHFFFAOYSA-N 0.000 claims 1
- ARPRJAMVDNNOMT-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=NC(=NC=N5)OC)O)C.Cl.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=NC(=NC=N5)OC)O)C.Cl.Cl ARPRJAMVDNNOMT-UHFFFAOYSA-N 0.000 claims 1
- QXZZNERSSNMHDQ-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=NN6C=CN=C6C=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=NN6C=CN=C6C=C5)O)C.Cl QXZZNERSSNMHDQ-UHFFFAOYSA-N 0.000 claims 1
- KYWXKZFVBMQRQY-UHFFFAOYSA-N CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=NN6C=NN=C6C=C5)O)C.Cl Chemical compound CC1(CC(CC(N1)(C)C)N2C3=NN=C(C=C3N=N2)C4=C(C=C(C=C4)C5=NN6C=NN=C6C=C5)O)C.Cl KYWXKZFVBMQRQY-UHFFFAOYSA-N 0.000 claims 1
- CSBJUXPHLKVWSL-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC(=NC=C1)C(F)(F)F)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC(=NC=C1)C(F)(F)F)O)(C)C)C CSBJUXPHLKVWSL-UHFFFAOYSA-N 0.000 claims 1
- LLUUWAIXIGURPB-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC=2N(C=C1)N=CN=2)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC=2N(C=C1)N=CN=2)O)(C)C)C LLUUWAIXIGURPB-UHFFFAOYSA-N 0.000 claims 1
- QRPNFWFAESPZOV-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC=2N(C=C1)N=NC=2)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC=2N(C=C1)N=NC=2)O)(C)C)C QRPNFWFAESPZOV-UHFFFAOYSA-N 0.000 claims 1
- SJJFQXDPRPTDDW-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC=C(C=C1)O)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC=C(C=C1)O)O)(C)C)C SJJFQXDPRPTDDW-UHFFFAOYSA-N 0.000 claims 1
- OVGMNSUGWLZSDU-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CN=CS1)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CN=CS1)O)(C)C)C OVGMNSUGWLZSDU-UHFFFAOYSA-N 0.000 claims 1
- XTEXURNNNAMPIJ-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CSC=C1)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CSC=C1)O)(C)C)C XTEXURNNNAMPIJ-UHFFFAOYSA-N 0.000 claims 1
- YBSZMQWTRMGMQI-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=CC=2N(N=1)C=NN=2)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=CC=2N(N=1)C=NN=2)O)(C)C)C YBSZMQWTRMGMQI-UHFFFAOYSA-N 0.000 claims 1
- DXNAKRLUCGVJEU-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1SC=CN=1)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1SC=CN=1)O)(C)C)C DXNAKRLUCGVJEU-UHFFFAOYSA-N 0.000 claims 1
- BSCBHDGQVZTZLE-UHFFFAOYSA-N CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1SC=NN=1)O)(C)C)C Chemical compound CC1(NC(CC(C1)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1SC=NN=1)O)(C)C)C BSCBHDGQVZTZLE-UHFFFAOYSA-N 0.000 claims 1
- CDCSEJKBOILEBA-UHFFFAOYSA-N CC1=CC=NN1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CC1=CC=NN1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C CDCSEJKBOILEBA-UHFFFAOYSA-N 0.000 claims 1
- DOHWIWKJZVGRLO-UHFFFAOYSA-N CC1=CN=C(S1)C2=CC(=C(C=C2)C3=NN=C4C(=C3)N=NN4C5CC(NC(C5)(C)C)(C)C)O.Cl Chemical compound CC1=CN=C(S1)C2=CC(=C(C=C2)C3=NN=C4C(=C3)N=NN4C5CC(NC(C5)(C)C)(C)C)O.Cl DOHWIWKJZVGRLO-UHFFFAOYSA-N 0.000 claims 1
- XJEYOUGWYYHRSH-UHFFFAOYSA-N CC1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CC1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C XJEYOUGWYYHRSH-UHFFFAOYSA-N 0.000 claims 1
- PYQQNCSCXQFGMO-UHFFFAOYSA-N CC1=NN(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CC1=NN(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C PYQQNCSCXQFGMO-UHFFFAOYSA-N 0.000 claims 1
- YLJHBGQTZFIKII-UHFFFAOYSA-N CC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C YLJHBGQTZFIKII-UHFFFAOYSA-N 0.000 claims 1
- COKAZEDTDINQIP-UHFFFAOYSA-N CC=1OC(=CN=1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CC=1OC(=CN=1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C COKAZEDTDINQIP-UHFFFAOYSA-N 0.000 claims 1
- XZMKNTZTVAGYFH-UHFFFAOYSA-N CN(C1=CC=C(C=N1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)C Chemical compound CN(C1=CC=C(C=N1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)C XZMKNTZTVAGYFH-UHFFFAOYSA-N 0.000 claims 1
- NXEPJRQTRBYXAO-UHFFFAOYSA-N CN(C1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)C Chemical compound CN(C1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)C NXEPJRQTRBYXAO-UHFFFAOYSA-N 0.000 claims 1
- QTPNFWZMBNTULA-UHFFFAOYSA-N CN1N=C(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CN1N=C(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C QTPNFWZMBNTULA-UHFFFAOYSA-N 0.000 claims 1
- AQEDLCXPALRUPH-UHFFFAOYSA-N CN1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CN1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C AQEDLCXPALRUPH-UHFFFAOYSA-N 0.000 claims 1
- JNKSCAAIDAPBDP-UHFFFAOYSA-N CN1N=CC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CN1N=CC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C JNKSCAAIDAPBDP-UHFFFAOYSA-N 0.000 claims 1
- HAHUVWOHNUHKIM-UHFFFAOYSA-N CNC1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound CNC1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C HAHUVWOHNUHKIM-UHFFFAOYSA-N 0.000 claims 1
- ZNSFSXYSTJPUPK-UHFFFAOYSA-N COC1=NC(=NC=N1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound COC1=NC(=NC=N1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C ZNSFSXYSTJPUPK-UHFFFAOYSA-N 0.000 claims 1
- MKKLUEGHXQUPTH-UHFFFAOYSA-N COC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound COC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C MKKLUEGHXQUPTH-UHFFFAOYSA-N 0.000 claims 1
- OBCDNXOFZPDSIO-GJDMYPNDSA-N C[C@]12CC(C[C@](CC1)(N2)C)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=NNC=1)O Chemical compound C[C@]12CC(C[C@](CC1)(N2)C)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=NNC=1)O OBCDNXOFZPDSIO-GJDMYPNDSA-N 0.000 claims 1
- PWCNKEWBVGFPBI-UHFFFAOYSA-N Cl.Cl.CN1C(CC(CC1(C)C)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=NNC=1)O)(C)C Chemical compound Cl.Cl.CN1C(CC(CC1(C)C)N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=NNC=1)O)(C)C PWCNKEWBVGFPBI-UHFFFAOYSA-N 0.000 claims 1
- WCXRTNTVHFKOKQ-UHFFFAOYSA-N FC(OC=1C=CC(=NC=1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)F Chemical compound FC(OC=1C=CC(=NC=1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C)F WCXRTNTVHFKOKQ-UHFFFAOYSA-N 0.000 claims 1
- GDAHALNLMUDALK-UHFFFAOYSA-N FC1=CC(=C(C=C1C1=CC=C(C=C1)O)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound FC1=CC(=C(C=C1C1=CC=C(C=C1)O)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C GDAHALNLMUDALK-UHFFFAOYSA-N 0.000 claims 1
- FIEBCNQTCOVUFG-UHFFFAOYSA-N FC1=NN(C=C1C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C)C Chemical compound FC1=NN(C=C1C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C)C FIEBCNQTCOVUFG-UHFFFAOYSA-N 0.000 claims 1
- UECIEINXBYIBJE-UHFFFAOYSA-N FC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound FC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C UECIEINXBYIBJE-UHFFFAOYSA-N 0.000 claims 1
- GWFQXHPQZZMPQA-UHFFFAOYSA-N FC=1C=NC=CC=1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound FC=1C=NC=CC=1C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C GWFQXHPQZZMPQA-UHFFFAOYSA-N 0.000 claims 1
- HFBKNGRWUHFVPQ-UGKGYDQZSA-N F[C@@H]1C(NC(C[C@@H]1N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC(N(C=C1)C)=O)O)(C)C)(C)C Chemical compound F[C@@H]1C(NC(C[C@@H]1N1N=NC2=C1N=NC(=C2)C1=C(C=C(C=C1)C1=CC(N(C=C1)C)=O)O)(C)C)(C)C HFBKNGRWUHFVPQ-UGKGYDQZSA-N 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims 1
- FSQSBVAAQCSWCM-UHFFFAOYSA-N N1(C(CC(CC1(C)C)N1C2=C(N=N1)C=C(C1=CC=C(C=3C=NNC=3)C=C1O)N=N2)(C)C)C Chemical compound N1(C(CC(CC1(C)C)N1C2=C(N=N1)C=C(C1=CC=C(C=3C=NNC=3)C=C1O)N=N2)(C)C)C FSQSBVAAQCSWCM-UHFFFAOYSA-N 0.000 claims 1
- HCJOFNWJQQERIO-UHFFFAOYSA-N N1=C(C=CC=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1=C(C=CC=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C HCJOFNWJQQERIO-UHFFFAOYSA-N 0.000 claims 1
- FHQBSEMQUDGOFL-UHFFFAOYSA-N N1=CC(=CC=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1=CC(=CC=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C FHQBSEMQUDGOFL-UHFFFAOYSA-N 0.000 claims 1
- UEDXZYBNXOLLJU-UHFFFAOYSA-N N1=CC(=CC=C1)C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1=CC(=CC=C1)C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C UEDXZYBNXOLLJU-UHFFFAOYSA-N 0.000 claims 1
- XHXBXPTZXXFGET-UHFFFAOYSA-N N1=CC=C(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1=CC=C(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C XHXBXPTZXXFGET-UHFFFAOYSA-N 0.000 claims 1
- JODJSEHTXZTFLG-UHFFFAOYSA-N N1=CN=CC(=C1)C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1=CN=CC(=C1)C=1C=CC(=C(C=1)O)C=1C=C2C(=NN=1)N(N=C2)C1CC(NC(C1)(C)C)(C)C JODJSEHTXZTFLG-UHFFFAOYSA-N 0.000 claims 1
- WWUWZMDBLQKHFB-UHFFFAOYSA-N N1=NC=C(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1=NC=C(C=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C WWUWZMDBLQKHFB-UHFFFAOYSA-N 0.000 claims 1
- UILVXCQQVSAXPF-UHFFFAOYSA-N N1C(CC(CC1(C)C)N1C2=C(N=N1)C=C(C1=NC=C(C=C1O)C=1C=NNC=1)N=N2)(C)C Chemical compound N1C(CC(CC1(C)C)N1C2=C(N=N1)C=C(C1=NC=C(C=C1O)C=1C=NNC=1)N=N2)(C)C UILVXCQQVSAXPF-UHFFFAOYSA-N 0.000 claims 1
- BMBROBQQCKNBKO-UHFFFAOYSA-N N1C=CC=2C1=NC=CC=2C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N1C=CC=2C1=NC=CC=2C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C BMBROBQQCKNBKO-UHFFFAOYSA-N 0.000 claims 1
- NQBWYLNVMBFSIN-UHFFFAOYSA-N N1CCC(CC1)C1=CNC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=NNC=1)O Chemical compound N1CCC(CC1)C1=CNC2=C1N=NC(=C2)C1=C(C=C(C=C1)C=1C=NNC=1)O NQBWYLNVMBFSIN-UHFFFAOYSA-N 0.000 claims 1
- RVAHNMDYQDRSDJ-UHFFFAOYSA-N N1CCC(N2C3=NC=C(N=C3C=N2)C2=CC=C(C=3C=NNC=3)C=C2O)CC1 Chemical compound N1CCC(N2C3=NC=C(N=C3C=N2)C2=CC=C(C=3C=NNC=3)C=C2O)CC1 RVAHNMDYQDRSDJ-UHFFFAOYSA-N 0.000 claims 1
- DHHGMXVHXODILS-UHFFFAOYSA-N N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)C(=CN2)C=1CC(NC(C=1)(C)C)(C)C Chemical compound N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)C(=CN2)C=1CC(NC(C=1)(C)C)(C)C DHHGMXVHXODILS-UHFFFAOYSA-N 0.000 claims 1
- XNYIAFCUBYILSN-UHFFFAOYSA-N N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)C(=CS2)C=1CCNCC=1 Chemical compound N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)C(=CS2)C=1CCNCC=1 XNYIAFCUBYILSN-UHFFFAOYSA-N 0.000 claims 1
- QUOQKLKFEJLOTO-UHFFFAOYSA-N N=1C=C(N2C=1C=NC=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N=1C=C(N2C=1C=NC=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C QUOQKLKFEJLOTO-UHFFFAOYSA-N 0.000 claims 1
- PCHPVTBEHDYBIV-UHFFFAOYSA-N N=1C=CN2C=1C=C(C=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N=1C=CN2C=1C=C(C=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C PCHPVTBEHDYBIV-UHFFFAOYSA-N 0.000 claims 1
- HEUANYLFLKGBKC-UHFFFAOYSA-N N=1C=CN2C=1C=NC(=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N=1C=CN2C=1C=NC(=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C HEUANYLFLKGBKC-UHFFFAOYSA-N 0.000 claims 1
- MHIYQAQITPPMMQ-UHFFFAOYSA-N N=1C=CN2C=1N=CC(=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N=1C=CN2C=1N=CC(=C2)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C MHIYQAQITPPMMQ-UHFFFAOYSA-N 0.000 claims 1
- WSLLXTMQGQIZNJ-UHFFFAOYSA-N N=1C=CN2N=C(C=CC2=1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound N=1C=CN2N=C(C=CC2=1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C WSLLXTMQGQIZNJ-UHFFFAOYSA-N 0.000 claims 1
- UESVQKLBZITWBV-UHFFFAOYSA-N NC1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound NC1=NC=CC(=C1)C=1C=CC(=C(C=1)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C UESVQKLBZITWBV-UHFFFAOYSA-N 0.000 claims 1
- LNAFRHAHLZMSDN-WGOQTCKBSA-N O\N=C\1/CCC2=CC(=C(C=C/12)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C Chemical compound O\N=C\1/CCC2=CC(=C(C=C/12)O)C1=CC2=C(N=N1)N(N=N2)C1CC(NC(C1)(C)C)(C)C LNAFRHAHLZMSDN-WGOQTCKBSA-N 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- LRCIGPJGANAIHK-UHFFFAOYSA-N benzene-1,4-diol;dihydrochloride Chemical compound Cl.Cl.OC1=CC=C(O)C=C1 LRCIGPJGANAIHK-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229960004337 hydroquinone Drugs 0.000 claims 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000002923 oximes Chemical class 0.000 claims 1
- GEOWCLRLLWTHDN-UHFFFAOYSA-N phenyl formate Chemical compound O=COC1=CC=CC=C1 GEOWCLRLLWTHDN-UHFFFAOYSA-N 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- HYHBKLWDTGTBME-UHFFFAOYSA-N pyrazin-1-ium;chloride Chemical compound Cl.C1=CN=CC=N1 HYHBKLWDTGTBME-UHFFFAOYSA-N 0.000 claims 1
- KNPBKKLNMDSNPI-UHFFFAOYSA-N pyridazin-1-ium 2,2,2-trifluoroacetate Chemical compound C1=CN=NC=C1.OC(=O)C(F)(F)F KNPBKKLNMDSNPI-UHFFFAOYSA-N 0.000 claims 1
- BEPZJGUUEAAGDN-UHFFFAOYSA-N pyridin-3-ol dihydrochloride Chemical compound Cl.Cl.Oc1cccnc1 BEPZJGUUEAAGDN-UHFFFAOYSA-N 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
Claims (12)
(式中、各破線は、利用できる価数により可能であれば存在してもよい結合を表し、
W1は、利用できる価数により可能であるC-Ra、CH-Ra、N、N-Rb、OおよびSからなる群から選択され、
W2は、利用できる価数により可能であるC-Ra、CH-Ra、NおよびN-Rb からなる群から選択され、
W3は、利用できる価数により可能であるC、CHおよびNからなる群から選択され、
W1、W2またはW3の少なくとも1つが、NまたはN-Rbであり、
W 1 がSまたはOである場合、W 2 がC-R a であり、W 3 がCであり、
W4およびW5は、独立して、C-RaまたはNであり、
Raが、各例において、水素、シアノ、ハロゲン、ヒドロキシ、C1-6アルキル、重水素-C1-4アルキル、ハロ-C1-6アルキル、C1-6アルコキシ、ハロ-C1-6アルコキシ、C1-6アルコキシ-C1-6アルキル、アミノ、C1-6アルキル-アミノ、(C1-6アルキル)2-アミノ、アミノ-C1-6アルキルおよびヒドロキシ-C1-6アルキルからなる群から独立して選択され、
Rbが、水素およびC1-6アルキルからなる群から選択され、
R1は、C3-10シクロアルキルおよびヘテロシクリルからなる群から選択され、
ヘテロシクリルが、N、OまたはSから独立して選択される1、2または3個のヘテロ原子環員を有する飽和または部分的不飽和3~7員環の単環式、6~10員環の二環式または13~16員環の多環式環系であり、
C3-10シクロアルキルおよびヘテロシクリルの各例が、1、2もしくは3個のR3置換基で置換されていてもよく、1個の追加のR4置換基で置換されていてもよく、または、
別法として、C3-10シクロアルキルおよびヘテロシクリルの各例が、1、2、3または4個のR3置換基で置換されていてもよく、
R2は、フェニル、ヘテロシクリルおよびヘテロアリールからなる群から選択され、
ヘテロシクリルが、N、OまたはSから独立して選択される1、2または3個のヘテロ原子環員を有する飽和または部分的不飽和3~7員環の単環式、6~10員環の二環式または13~16員環の多環式環系であり、
ヘテロアリールが、N、OまたはSから独立して選択される1、2、3または4個のヘテロ原子環員を有する3~7員環の単環式または6~10員環の二環式環系であり、
フェニル、ヘテロシクリルおよびヘテロアリールの各例が、1、2または3個のR5置換基で置換されていてもよく、1個の追加のR6置換基で置換されていてもよく、
R3が、各例において、シアノ、ハロゲン、ヒドロキシ、C1-6アルキル、重水素-C1-4アルキル、ハロ-C1-6アルキル、C1-6アルコキシ、ハロ-C1-6アルコキシ、C1-6アルコキシ-C1-6アルキル、アミノ、C1-6アルキル-アミノ、(C1-6アルキル)2-アミノ、アミノ-C1-6アルキルおよびヒドロキシ-C1-6アルキルからなる群から独立して選択され、
R4が、C3-10シクロアルキル、フェニル、ヘテロアリールおよびヘテロシクリルからなる群から選択され、
ヘテロシクリルが、N、OまたはSから独立して選択される1、2または3個のヘテロ原子環員を有する飽和または部分的不飽和3~7員環の単環式、6~10員環の二環式または13~16員環の多環式環系であり、
ヘテロアリールが、N、OまたはSから独立して選択される1、2、3または4個のヘテロ原子環員を有する3~7員環の単環式または6~10員環の二環式環系であり、
C3-10シクロアルキル、フェニル、ヘテロシクリルおよびヘテロアリールの各例が、1、2または3個のR7置換基で置換されていてもよく、
R5が、各例において、ハロゲン、ヒドロキシ、シアノ、ニトロ、C1-6アルキル、重水素-C1-4アルキル、ハロ-C1-6アルキル、C1-6アルコキシ、ハロ-C1-6アルコキシ、オキシム、アミノ、C1-6アルキル-アミノ、(C1-6アルキル)2-アミノおよびC1-6アルキル-チオからなる群から独立して選択され、
R6が、フェニルおよびヘテロアリールからなる群から選択され、
ヘテロアリールが、N、OまたはSから独立して選択される1、2、3または4個のヘテロ原子環員を有する3~7員環の単環式または6~10員環の二環式環系であり、
フェニルおよびヘテロアリールの各例が、1、2、3または4個のR8置換基で置換されていてもよく
R7が、各例において、シアノ、ハロゲン、ヒドロキシ、C1-6アルキル、重水素-C1-4アルキル、ハロ-C1-6アルキル、C1-6アルコキシ、ハロ-C1-6アルコキシ、C1-6アルコキシ-C1-6アルキル、アミノ、C1-6アルキル-アミノ、(C1-6アルキル)2-アミノ、アミノ-C1-6アルキルおよびC3-10シクロアルキルからなる群から独立して選択され、
R8が、各例において、シアノ、ハロゲン、ヒドロキシ、C1-6アルキル、重水素-C1-4アルキル、ハロ-C1-6アルキル、C1-6アルコキシ、ハロ-C1-6アルコキシ、C1-6アルコキシ-C1-6アルキル、アミノ、C1-6アルキル-アミノ、(C1-6アルキル)2-アミノ、アミノ-C1-6アルキルおよびC3-10シクロアルキルからなる群から独立して選択される) The compound of formula (I), or a form thereof, in which the form of the compound is a salt, a hydrate, a solvate, a racemic compound, a mirror isomer, a diastereoisomer, a stereoisomer and a tautovariant thereof. A compound selected from the group consisting of morphologies.
(In the equation, each dashed line represents a bond that may exist if possible depending on the valence available.
W 1 is selected from the group consisting of C-R a , CH-R a , N, N-R b , O and S, which is possible depending on the valence available.
W 2 is selected from the group consisting of C-R a , CH-R a , N and N-R b , which is possible depending on the valence available.
W 3 is selected from the group consisting of C, CH and N, which is possible depending on the valence available.
At least one of W 1 , W 2 or W 3 is N or N-R b .
If W 1 is S or O, then W 2 is C—R a and W 3 is C.
W 4 and W 5 are independently CR a or N ,
R a is hydrogen, cyano, halogen, hydroxy, C 1-6 alkyl, deuterium-C 1-4 alkyl, halo-C 1-6 alkyl, C 1-6 alkoxy, halo-C 1- in each example. 6 Alkoxy, C 1-6 Alkoxy-C 1-6 Alkoxy, Amino, C 1-6 Alkoxy-Amino, (C 1-6 Alkoxy) 2 -Amino, Amino-C 1-6 Alkyl and Hydroxy-C 1-6 Selected independently from the group consisting of alkyl,
R b is selected from the group consisting of hydrogen and C 1-6 alkyl.
R 1 is selected from the group consisting of C 3-10 cycloalkyl and heterocyclyl.
Heterocyclyl is a saturated or partially unsaturated 3- to 7-membered monocyclic, 6-10-membered ring with 1, 2 or 3 heteroatom rings independently selected from N, O or S. Bicyclic or 13-16 membered polycyclic ring system,
Each example of C 3-10 cycloalkyl and heterocyclyl may be substituted with 1, 2 or 3 R 3 substituents, with one additional R 4 substituent, or ,
Alternatively, each example of C 3-10 cycloalkyl and heterocyclyl may be substituted with 1, 2, 3 or 4 R 3 substituents.
R 2 is selected from the group consisting of phenyl, heterocyclyl and heteroaryl,
Heterocyclyl is a saturated or partially unsaturated 3- to 7-membered monocyclic, 6-10-membered ring with 1, 2 or 3 heteroatom rings independently selected from N, O or S. Bicyclic or 13-16 membered polycyclic ring system,
The heteroaryl is a 3- to 7-membered monocyclic or 6 to 10-membered bicyclic ring with 1, 2, 3 or 4 heteroatom rings independently selected from N, O or S. It is a cyclic system
Examples of phenyl, heterocyclyl and heteroaryl may be substituted with 1, 2 or 3 R 5 substituents or with one additional R 6 substituent.
R 3 is cyano, halogen, hydroxy, C 1-6 alkyl, deuterium-C 1-4 alkyl, halo-C 1-6 alkyl, C 1-6 alkoxy, halo-C 1-6 alkoxy in each example. , C 1-6 Alkoxy-C 1-6 Alkyl, Amino, C 1-6 Alkoxy-Amino, (C 1-6 Alkyl) 2 -Amino, Amino-C 1-6 Alkyl and Hydroxy-C 1-6 Alkyl Selected independently of the group
R 4 is selected from the group consisting of C 3-10 cycloalkyl, phenyl, heteroaryl and heterocyclyl.
Heterocyclyl is a saturated or partially unsaturated 3- to 7-membered monocyclic, 6-10-membered ring with 1, 2 or 3 heteroatom rings independently selected from N, O or S. Bicyclic or 13-16 membered polycyclic ring system,
The heteroaryl is a 3- to 7-membered monocyclic or 6 to 10-membered bicyclic ring with 1, 2, 3 or 4 heteroatom rings independently selected from N, O or S. It is a cyclic system
Examples of C 3-10 cycloalkyl, phenyl, heterocyclyl and heteroaryl may be substituted with 1, 2 or 3 R 7 substituents.
R 5 is, in each example, halogen, hydroxy, cyano, nitro, C 1-6 alkyl, deuterium-C 1-4 alkyl, halo-C 1-6 alkyl, C 1-6 alkoxy, halo-C 1- 6 Independently selected from the group consisting of alkoxy, oxime, amino, C 1-6 alkyl-amino, (C 1-6 alkyl) 2 -amino and C 1-6 alkyl-thio,
R 6 is selected from the group consisting of phenyl and heteroaryl,
The heteroaryl is a 3- to 7-membered monocyclic or 6 to 10-membered bicyclic ring with 1, 2, 3 or 4 heteroatom rings independently selected from N, O or S. It is a cyclic system
Each example of phenyl and heteroaryl may be substituted with 1, 2, 3 or 4 R 8 substituents, where R 7 is cyano, halogen, hydroxy, C 1-6 alkyl, heavy in each example. Hydrogen-C 1-4 Alkoxy, Halo-C 1-6 Alkoxy, C 1-6 Alkoxy, Halo-C 1-6 Alkoxy, C 1-6 Alkoxy-C 1-6 Alkoxy, Amino, C 1-6 Alkoxy- Selected independently from the group consisting of amino, (C 1-6 alkyl) 2 -amino, amino-C 1-6 alkyl and C 3-10 cycloalkyl,
R 8 is cyano, halogen, hydroxy, C 1-6 alkyl, deuterium-C 1-4 alkyl, halo-C 1-6 alkyl, C 1-6 alkoxy, halo-C 1-6 alkoxy in each example. , C 1-6 Alkoxy-C 1-6 Alkoxy, Amino, C 1-6 Alkoxy-Amino, (C 1-6 Alkyl) 2 -Amino, Amino-C 1-6 Alkyl and C 3-10 Cycloalkyl Selected independently of the group )
5-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-イミダゾ[4,5-b]ピラジン;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]フェノール;
3-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン;
2-[6-メチル-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
3-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-6-メチル-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン;
5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[5-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)-5H-ピロロ[2,3-b]ピラジン-2-イル]フェノール;
3-[2-ヒドロキシ-4-(1H-ピラゾール-4-イル)フェニル]-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-6-オール;
5-(1H-ピラゾール-4-イル)-2-[5-(2,2,6,6-テトラメチルピペリジン-4-イル)-5H-ピロロ[2,3-b]ピラジン-2-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(1,2,3,6-テトラヒドロピリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]フェノール;
2-[7-(ピペリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
6-[2,3-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン;
6-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン;
5-(1H-ピラゾール-4-イル)-2-[7-(1,2,3,6-テトラヒドロピリジン-4-イル)チエノ[3,2-c]ピリダジン-3-イル]フェノール;
2-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-5-(2,2,6,6-テトラメチルピペリジン-4-イル)-5H-ピロロ[2,3-b]ピラジン;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)チエノ[3,2-c]ピリダジン-3-イル]フェノール;
2-[7-(8-アザビシクロ[3.2.1]オクタ-2-エン-3-イル)チエノ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-[1-(ピペリジン-4-イル)-1H-ピラゾロ[3,4-b]ピラジン-5-イル]-5-(1H-ピラゾール-4-イル)フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]フェノール;
2-[1-(ピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]-5-(1H-ピラゾール-4-イル)フェノール;
5-(1H-ピラゾール-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-6,7-ジヒドロ-5H-ピロロ[2,3-c]ピリダジン-3-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)チエノ[3,2-c]ピリダジン-3-イル]フェノール;
2-[7-(3-オキサ-9-アザビシクロ[3.3.1]ノナ-6-エン-7-イル)チエノ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-ピロロ[2,3-c]ピリダジン-3-イル]フェノール;
2-[7-(8-アザビシクロ[3.2.1]オクタ-2-エン-3-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-[7-(3-オキサ-9-アザビシクロ[3.3.1]ノナ-6-エン-7-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-[7-(8-アザビシクロ[3.2.1]オクタ-3-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-[7-(3-オキサ-9-アザビシクロ[3.3.1]ノナ-7-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]フェノール;
3-[2,3-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-6,7-ジヒドロ-5H-ピロロ[2,3-c]ピリダジン;
4-フルオロ-2-(1H-ピラゾール-4-イル)-5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-ピラゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
4-フルオロ-5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
7-[(3-exo)-8-アザビシクロ[3.2.1]オクタ-3-イル]-3-[2,3-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-6,7-ジヒドロ-5H-ピロロ[2,3-c]ピリダジン;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1-メチルピリジン-2(1H)-オン;
4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]ビフェニル-3,4’-ジオール;
5-(1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[6-メトキシ-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-[6-(メチルアミノ)-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-[7-(ピペラジン-1-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
5-(1-エチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1-プロピル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-ピラゾール-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[6-(エチルアミノ)-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール;
5-(1-メチル-1H-ピラゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1-メチル-1H-ピラゾール-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(1,2,2,6,6-ペンタメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-ピラゾール-4-イル)フェノール;
6-フルオロ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル][1,1’-ビフェニル]-3,4’-ジオール;
2-フルオロ-3-(1H-ピラゾール-4-イル)-6-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
4-{2-フルオロ-5-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1-メチルピリジン-2(1H)-オン;
2-[3-(2,2-ジメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-ピラゾール-4-イル)フェノール;
2-{3-[(1R,5S)-1,5-ジメチル-8-アザビシクロ[3.2.1]オクタン-3-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール;
2-(1H-ピラゾール-4-イル)-5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]ベンゼン-1,4-ジオール;
3-フルオロ-5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(ピラジン-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(ピリジン-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
4-フルオロ-5-(1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-1,2,4-トリアゾール-1-イル)フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(4H-1,2,4-トリアゾール-4-イル)フェノール;
5-(ピリジン-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(ピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
6-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリジン-3-オール;
2-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリミジン-5-オール;
5-[1-(2H3)メチル-1H-ピラゾール-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-[1-(ジフルオロメチル)-1H-ピラゾール-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-1,2,3-トリアゾール-1-イル)フェノール;
5-(2-メチルピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-[2-(トリフルオロメチル)ピリジン-4-イル]フェノール;
5-(ピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(ピリダジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(2-メトキシピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(ピリミジン-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
6-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリダジン-3-オール;
5-(1H-ピロール-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
6-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]キノリン-7-オール;
(3E)-3-(ヒドロキシイミノ)-6-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-2,3-ジヒドロ-1H-インデン-5-オール;
4-クロロ-5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-[6-(ジメチルアミノ)ピリジン-3-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(イミダゾ[1,2-a]ピラジン-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
1-シクロプロピル-4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリジン-2(1H)-オン;
4-フルオロ-5-(ピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(イミダゾ[1,5-a]ピリジン-7-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(チオフェン-3-イル)フェノール;
5-(イミダゾ[1,2-a]ピリジン-7-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-イミダゾール-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
1-メチル-5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-1H-ベンゾイミダゾール-6-オール;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリジン-2(1H)-オン;
5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-1H-インダゾール-6-オール;
5-(フラン-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,3-チアゾール-2-イル)フェノール;
2-メチル-5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-1H-ベンゾイミダゾール-6-オール;
5-(1-メチル-1H-ピラゾール-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
5-(2-アミノピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-[2-(ジメチルアミノ)ピリジン-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(3-フルオロピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-[1-(2H3)メチル-1H-ピラゾール-4-イル]-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
5-[5-(ジフルオロメトキシ)ピリジン-2-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-[2-(メチルアミノ)ピリジン-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)フロ[3,2-c]ピリダジン-3-イル]フェノール;
5-(3-フルオロ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,3-チアゾール-5-イル)フェノール;
5-(3-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1H-ピラゾール-3-カルボニトリル;
2-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1,3-チアゾール-5-カルボニトリル;
5-(1,3-オキサゾール-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-1,2,3-トリアゾール-4-イル)フェノール;
5-(6-メトキシピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-[2-(ジフルオロメトキシ)ピリジン-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-イミダゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,3,4-チアジアゾール-2-イル)フェノール;
6-[4-(1H-ピラゾール-4-イル)-1H-ベンゾトリアゾール-7-イル]-3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン;
5-(1H-ピロロ[2,3-b]ピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(2-メトキシピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1,2-オキサゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(5-フルオロ-1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1-エチル-5-フルオロ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(2-エトキシピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(6-エトキシピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-([1,2,3]トリアゾロ[1,5-a]ピリジン-5-イル)フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-([1,2,4]トリアゾロ[1,5-a]ピリジン-7-イル)フェノール;
5-(3-クロロ-1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
6-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリミジン-4(3H)-オン;
5-(3-クロロ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール
5-(3-フルオロ-1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(3-メトキシ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1-メチル-1H-ピラゾール-3-カルボニトリル;
5-(5-メチル-1,3-チアゾール-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,2,4-チアジアゾール-5-イル)フェノール;
5-(4-フルオロ-1H-ベンゾトリアゾール-6-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-ピロロ[2,3-c]ピリダジン-3-イル]ピリジン-3-オール;
5-(3-ブロモ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(1-メチル-1H-1,2,3-トリアゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-[3-(トリフルオロメチル)-1H-ピラゾール-4-イル]フェノール;
5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]ピリジン-3-オール;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]ピリジン-3-オール;
5-(イミダゾ[1,2-a]ピラジン-6-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(4-フルオロ-1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(4-メチル-1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-[1,2,3]トリアゾロ[4,5-b]ピリジン-6-イル)フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(3H-[1,2,3]トリアゾロ[4,5-c]ピリジン-6-イル)フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-[1,2,3]トリアゾロ[4,5-b]ピリジン-5-イル)フェノール;
5-(3-フルオロ-1-メチル-1H-ピラゾール-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
5-(2,4-ジメチル-1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(2-メチル-1,3-チアゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(2-メチル-2H-1,2,3-トリアゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-([1,2,4]トリアゾロ[4,3-b]ピリダジン-6-イル)フェノール;
5-(3-メチル-1,2,4-チアジアゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(4-フルオロ-2-メチル-1,3-チアゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(5-メチル-1H-ピラゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(4-メチル-1H-ピラゾール-1-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール;
5-(3-メチル-1H-ピラゾール-1-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール;
5-(2-メチル-1,3-オキサゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール;
5-(4-メトキシ-1,3,5-トリアジン-2-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール;
5-(イミダゾ[1,2-a]ピリミジン-6-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール;
5-(3-フルオロ-1H-ピラゾール-4-イル)-2-(1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル)フェノール;
5-(イミダゾ[1,2-b]ピリダジン-6-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(2H-1,2,3-トリアゾール-2-イル)フェノール;
2-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール;
5-(ピリジン-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
5-(ピリジン-3-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
5-(ピリミジン-5-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
2-{3-[(3S,4R)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール;
5-(1-メチル-1H-ピラゾール-3-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール;
2-{3-[3-(tert-ブチルアミノ)シクロブチル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール;
4-(4-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-3-ヒドロキシフェニル)-1-メチルピリジン-2(1H)-オン;
6-(4-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-3-ヒドロキシフェニル)-3-メチルピリミジン-4(3H)-オン;
5-(3-フルオロ-1H-ピラゾール-4-イル)-2-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}フェノール;
2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]-5-(2H-1,2,3-トリアゾール-2-イル)フェノール;
2-{3-[3-(tert-ブチルアミノ)シクロペンチル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール;および
2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-ピロロ[2,3-c]ピリダジン-3-イル]-5-(2H-1,2,3-トリアゾール-2-イル)フェノール;
からなる群から選択される化合物、またはその形態であって、化合物の形態が、その塩、水和物、溶媒和物、ラセミ化合物、鏡像異性体、ジアステレオ異性体、立体異性体および互変異性体形態からなる群から選択される、化合物。 5- (1H-Pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-imidazole [4,5-b] pyrazine-5-yl ] Phenol;
5- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-imidazole [4,5 -B] Pyrazine;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl ] Phenol;
3- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -7- (2,2,6,6-tetramethylpyridazine-4-yl) -7H-imidazole [4,5 -C] Pyridazine;
2- [6-Methyl-7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenol;
3- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -6-methyl-7- (2,2,6,6-tetramethylpyridazine-4-yl) -7H-imidazole [4,5-c] Pyridazine;
5- (1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Phenol;
5- (1H-Pyrazole-4-yl) -2- [5- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) -5H-pyrrolo [2] , 3-b] Pyrazine-2-yl] Phenol;
3- [2-Hydroxy-4- (1H-pyrazole-4-yl) phenyl] -7- (2,2,6,6-tetramethylpyridazine-4-yl) -7H-imidazole [4,5-c ] Pyridazine-6-all;
5- (1H-Pyrazole-4-yl) -2- [5- (2,2,6,6-tetramethylpiperidine-4-yl) -5H-pyrolo [2,3-b] pyrazine-2-yl ] Phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (1,2,3,6-tetrahydropyridine-4-yl) -5H-pyrolo [3,2-c] pyridazine-3-yl] Phenol;
2- [7- (Piperidin-4-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) phenol;
6- [2,3-difluoro-4- (1H-pyrazole-4-yl) phenyl] -3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine;
6- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine;
5- (1H-Pyrazole-4-yl) -2- [7- (1,2,3,6-tetrahydropyridine-4-yl) thieno [3,2-c] pyridazine-3-yl] phenol;
2- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -5- (2,2,6,6-tetramethylpiperidine-4-yl) -5H-pyrrolo [2,3 -B] Pyrazine;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) Thieno [3,2- c] Pyridazine-3-yl] Phenol;
2- [7- (8-azabicyclo [3.2.1] octa-2-en-3-yl) thieno [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) Il) Phenol;
2- [1- (Piperidin-4-yl) -1H-pyrazolo [3,4-b] pyrazine-5-yl] -5- (1H-pyrazole-4-yl) phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) -5H-pyrrolo [3 , 2-c] pyridazine-3-yl] phenol;
2- [1- (Piperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] -5- (1H-pyrazole-4-yl) phenol;
5- (1H-Pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl ] Phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpyridazine-4-yl) -6,7-dihydro-5H-pyrrolo [2,3-c] ] Pyridazine-3-yl] Phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) thieno [3,2-c] pyridazine-3-yl] phenol;
2- [7- (3-oxa-9-azabicyclo [3.3.1] nona -6-en-7-yl) thieno [3,2-c] pyridazine-3-yl] -5- (1H) -Pyrazole-4-yl) Phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-pyrolo [2,3-c] pyridazine-3-yl ] Phenol;
2- [7- (8-azabicyclo [3.2.1] octa-2-en-3-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenol;
2- [7- (3-oxa-9-azabicyclo [3.3.1] nona-6-en-7-yl) -5H-pyrolo [3,2-c] pyridazine-3-yl] -5 (1H-pyrazole-4-yl) phenol;
2- [7- (8-azabicyclo [3.2.1] octa-3-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) ) Phenol;
2- [7- (3-oxa-9-azabicyclo [3.3.1] nona-7-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidin-4-yl) -5H-pyrolo [3,2-c] pyridazine-3-yl ] Phenol;
3- [2,3-difluoro-4- (1H-pyrazole-4-yl) phenyl] -7- (2,2,6,6-tetramethylpyridazine-4-yl) -6,7-dihydro-5H -Pyrolo [2,3-c] pyridazine;
4-Fluoro-2- (1H-pyrazole-4-yl) -5- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (1H-Pyrazole-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Phenol;
4-Fluoro-5- (1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
7-[(3-exo) -8-azabicyclo [3.2.1] octa-3-yl] -3- [2,3-difluoro-4- (1H-pyrazole-4-yl) phenyl] -6 , 7-Dihydro-5H-pyrrolo [2,3-c] pyridazine;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} -1-Methylpyridine-2 (1H) -on;
4- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] biphenyl-3, 4'-diol;
5- (1-Methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
2- [6-Methoxy-7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenol;
2- [6- (Methylamino) -7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5-( 1H-pyrazole-4-yl) phenol;
2- [7- (Piperazine-1-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) phenol;
5- (1-Ethyl-1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (1-propyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (1H-Pyrazole-3-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Phenol;
2- [6- (Ethylamino) -7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5-( 1H-pyrazole-4-yl) phenol;
5- (1-Methyl-1H-pyrazole-5-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (1-Methyl-1H-pyrazole-3-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
2- [3- (1,2,2,6,6-pentamethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5 -(1H-pyrazole-4-yl) phenol;
6-Fluoro-4- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] [1,1'-biphenyl] -3,4'-diol;
2-Fluoro-3- (1H-pyrazole-4-yl) -6- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
4- {2-Fluoro-5-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] ] Pyridazine-6-yl] Phenyl} -1-Methylpyridine-2 (1H) -on;
2- [3- (2,2-Dimethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5- (1H-pyrazole-4) -Il) Phenol;
2- {3-[(1R, 5S) -1,5-dimethyl-8-azabicyclo [3.2.1] octane-3-yl] -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl} -5- (1H-pyrazole-4-yl) phenol;
2- (1H-Pyrazole-4-yl) -5- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-] c] Pyridazine-6-yl] Benzene-1,4-diol;
3-Fluoro-5- (1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (Pyrazine-2-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol;
5- (Pyridine-2-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol;
4-Fluoro-5- (1-Methyl-1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H-1,2,4-triazole-1-yl) phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 4H-1,2,4-triazole-4-yl) phenol;
5- (Pyridine-3-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol;
5- (Pyridine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol;
6- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyridine-3-ol;
2- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyrimidine-5-ol;
5- [1- (2H 3 ) Methyl - 1H-Pyrazole-4-yl] -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2 , 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-] c] Pyridazine-6-yl] Phenol;
5- [1- (difluoromethyl) -1H-pyrazole-4-yl] -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3 ] Triazolo [4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H-1,2,3-triazole-1-yl) phenol;
5- (2-Methylpyridine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl] Phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-[ 2- (Trifluoromethyl) Pyridine-4-yl] phenol;
5- (Pyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyrimidine-6-yl] phenol;
5- (Pyridazine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol;
5- (2-Methoxypyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5] -C] Pyridazine-6-yl] Phenol;
5- (Pyrimidine-5-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyrimidine-6-yl] phenol;
6- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyridazine-3-ol;
5- (1H-Pyrrole-3-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Phenol;
6- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] quinoline-7- All;
(3E) -3- (Hydroxyimino) -6- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c ] Pyridazine-6-yl] -2,3-dihydro-1H-inden-5-ol;
4-Chloro-5- (1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- [6- (dimethylamino) Pyridine-3-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol;
5- (Imidazo [1,2-a] pyrazine-3-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
1-Cyclopropyl-4- {3-hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Phenyl} Pyridine-2 (1H) -on;
4-Fluoro-5- (pyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4, 5-c] Pyridazine-6-yl] Phenol;
5- (Imidazo [1,5-a] Pyridine-7-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( Thiophene-3-yl) phenol;
5- (Imidazo [1,2-a] Pyridine-7-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (1H-imidazol-2-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-] c] Pyridazine-6-yl] Phenol;
1-Methyl-5- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -1H-benzimidazole-6-ol;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyridine-2 (1H) -On;
5- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -1H-indazole -6-all;
5- (Fran-3-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,3-thiazole-2-yl) phenol;
2-Methyl-5- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -1H-benzimidazole-6-ol;
5- (1-Methyl-1H-pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine -5-Il] Phenol;
5- (2-Aminopyridine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl] Phenol;
5- [2- (Dimethylamino) Pyridine-4-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol;
5- (3-Fluoropyridine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl] Phenol;
5- [1- (2H 3 ) Methyl - 1H-pyrazole-4-yl] -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3, 4-c] pyridazine-5-yl] phenol;
5- [5- (difluoromethoxy) Pyridine-2-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol;
5- [2- (Methylamino) Pyridine-4-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) flow [3,2- c] Pyridazine-3-yl] Phenol;
5- (3-Fluoro-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,3-thiazole-5-yl) phenol;
5- (3-Methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} -1H-Pyrazole-3-Carbonitrile;
2- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} -1,3-thiazole-5-carbonitrile;
5- (1,3-Oxazole-2-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4, 5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H-1,2,3-triazole-4-yl) phenol;
5- (6-Methoxypyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyrimidine-6-yl] Phenol;
5- [2- (Difluoromethoxy) Pyridine-4-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol;
5- (1H-imidazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-] c] Pyridazine-6-yl] Phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,3,4-Thiadiazole-2-yl) phenol;
6- [4- (1H-Pyrazole-4-yl) -1H-benzotriazole-7-yl] -3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazoro [4,5-c] pyridazine;
5- (1H-pyrrolo [2,3-b] pyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (2-Methoxypyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5] -C] Pyrimidine-6-yl] Phenol;
5- (1,2-oxazol-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4, 5-c] pyridazine-6-yl] phenol;
5- (5-Fluoro-1-methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (1-Ethyl-5-Fluoro-1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (2-ethoxypyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5] -C] Pyridazine-6-yl] Phenol;
5- (6-ethoxypyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyrimidine-6-yl] Phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( [1,2,3] Triazolo [1,5-a] Pyridine-5-yl) Phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( [1,2,4] Triazolo [1,5-a] Pyridine-7-yl) Phenol;
5- (3-Chloro-1-methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
6- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyrimidine-4 (3H) -On;
5- (3-Chloro-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol 5- (3-Fluoro-1-methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine) -4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (3-Methoxy-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} -1-Methyl-1H-Pyrazole-3-Carbonitrile;
5- (5-Methyl-1,3-thiazole-2-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,2,4-Thiadiazole-5-yl) phenol;
5- (4-Fluoro-1H-benzotriazole-6-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-pyrolo [2,3-c] pyridazine-3-yl ] Pyridine-3-ol;
5- (3-bromo-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (1-Methyl-1H-1,2,3-triazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-[ 3- (Trifluoromethyl) -1H-pyrazole-4-yl] phenol;
5- (1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Pyridine-3-ol;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl ] Pyridine-3-ol;
5- (Imidazo [1,2-a] pyrazine-6-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (4-Fluoro-1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (4-Methyl-1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H- [1,2,3] triazolo [4,5-b] pyridazine-6-yl) phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl) phenol;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H- [1,2,3] triazolo [4,5-b] pyridazine-5-yl) phenol;
5- (3-Fluoro-1-methyl-1H-pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4 -C] pyridazine-5-yl] phenol;
5- (2,4-dimethyl-1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (2-Methyl-1,3-thiazole-5-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (2-Methyl-2H-1,2,3-triazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( [1,2,4] triazolo [4,3-b] pyridazine-6-yl) phenol;
5- (3-Methyl-1,2,4-thiadiazole-5-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (4-Fluoro-2-methyl-1,3-thiazole-5-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (5-Methyl-1H-pyrazole-1-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol;
5- (4-Methyl-1H-pyrazole-1-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl) Phenol;
5- (3-Methyl-1H-pyrazole-1-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl) Phenol;
5- (2-Methyl-1,3-oxazol-5-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol;
5- (4-Methoxy-1,3,5-triazine-2-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl) phenol;
5- (Imidazo [1,2-a] pyrimidin-6-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl) phenol;
5- (3-Fluoro-1H-pyrazole-4-yl) -2- (1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine -5-Il) Phenol;
5- (Imidazo [1,2-b] pyridazine-6-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl) phenol;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 2H-1,2,3-triazole-2-yl) phenol;
2- {3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl} -5- (1H-pyrazole-4-yl) phenol;
5- (Pyridine-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] phenol ;
5- (Pyridine-3-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] phenol ;
5- (Pyrimidine-5-yl) -2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] phenol ;
2- {3-[(3S, 4R) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl} -5- (1H-pyrazole-4-yl) phenol;
5- (1-Methyl-1H-pyrazole-3-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine -5-Il] Phenol;
2- {3- [3- (tert-butylamino) cyclobutyl] -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl} -5- (1H-pyrazole-4-) Il) Phenol;
4- (4- {3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpiperidine-4-yl] -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl} -3-hydroxyphenyl) -1-methylpyridine-2 (1H) -on;
6- (4- {3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H- [1,2,3] triazolo [4,5] -C] Pyridazine-6-yl} -3-hydroxyphenyl) -3-methylpyrimidine-4 (3H) -on;
5- (3-Fluoro-1H-pyrazole-4-yl) -2-{3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H -[1,2,3] triazolo [4,5-c] pyridazine-6-yl} phenol;
2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] -5- (2H-1,2,3) -Triazole-2-yl) phenol;
2- {3- [3- (tert-butylamino) cyclopentyl] -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl} -5- (1H-pyrazole-4-) Il) Phenol; and 2- [7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-pyrolo [2,3-c] pyridazine-3-yl] -5- (2H-) 1,2,3-triazole-2-yl) phenol;
A compound selected from the group consisting of , or a form thereof, wherein the form of the compound is a salt, a hydrate, a solvate, a racemic compound, a mirror isomer, a diastereoisomer, a stereoisomer and tautomer. A compound selected from the group consisting of isomers.
5-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-イミダゾ[4,5-b]ピラジン塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]フェノール塩酸塩;
3-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン塩酸塩;
2-[6-メチル-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
3-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-6-メチル-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[5-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)-5H-ピロロ[2,3-b]ピラジン-2-イル]フェノール塩酸塩;
3-[2-ヒドロキシ-4-(1H-ピラゾール-4-イル)フェニル]-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-6-オール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[5-(2,2,6,6-テトラメチルピペリジン-4-イル)-5H-ピロロ[2,3-b]ピラジン-2-イル]フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(1,2,3,6-テトラヒドロピリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
2-[7-(ピペリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
6-[2,3-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン塩酸塩;
6-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(1,2,3,6-テトラヒドロピリジン-4-イル)チエノ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
2-[2,5-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-5-(2,2,6,6-テトラメチルピペリジン-4-イル)-5H-ピロロ[2,3-b]ピラジン塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)チエノ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
2-[7-(8-アザビシクロ[3.2.1]オクタ-2-エン-3-イル)チエノ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[1-(ピペリジン-4-イル)-1H-ピラゾロ[3,4-b]ピラジン-5-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
2-[1-(ピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-6,7-ジヒドロ-5H-ピロロ[2,3-c]ピリダジン-3-イル]フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)チエノ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
2-[7-(3-オキサ-9-アザビシクロ[3.3.1]ノナ-6-エン-7-イル)チエノ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-ピロロ[2,3-c]ピリダジン-3-イル]フェノール塩酸塩;
2-[7-(8-アザビシクロ[3.2.1]オクタ-2-エン-3-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[7-(3-オキサ-9-アザビシクロ[3.3.1]ノナ-6-エン-7-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[7-(8-アザビシクロ[3.2.1]オクタ-3-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[7-(3-オキサ-9-アザビシクロ[3.3.1]ノナ-7-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-5H-ピロロ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
3-[2,3-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-6,7-ジヒドロ-5H-ピロロ[2,3-c]ピリダジン塩酸塩;
4-フルオロ-2-(1H-ピラゾール-4-イル)-5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
4-フルオロ-5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール臭化水素酸塩;
7-[(3-exo)-8-アザビシクロ[3.2.1]オクタ-3-イル]-3-[2,3-ジフルオロ-4-(1H-ピラゾール-4-イル)フェニル]-6,7-ジヒドロ-5H-ピロロ[2,3-c]ピリダジン塩酸塩;
4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]ビフェニル-3,4’-ジオール臭化水素酸塩;
5-(1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール臭化水素酸塩;
2-[6-メトキシ-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[6-(メチルアミノ)-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[6-(エチルアミノ)-7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-[3-(1,2,2,6,6-ペンタメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-ピラゾール-4-イル)フェノール二塩酸塩;
6-フルオロ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル][1,1’-ビフェニル]-3,4’-ジオール臭化水素酸塩;
2-フルオロ-3-(1H-ピラゾール-4-イル)-6-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
4-{2-フルオロ-5-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1-メチルピリジン-2(1H)-オン塩酸塩;
2-[3-(2,2-ジメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-{3-[(1R,5S)-1,5-ジメチル-8-アザビシクロ[3.2.1]オクタン-3-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール塩酸塩;
2-(1H-ピラゾール-4-イル)-5-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]ベンゼン-1,4-ジオール二塩酸塩;
3-フルオロ-5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(ピラジン-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(ピリジン-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
4-フルオロ-5-(1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-1,2,4-トリアゾール-1-イル)フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(4H-1,2,4-トリアゾール-4-イル)フェノール塩酸塩;
5-(ピリジン-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(ピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
6-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリジン-3-オール二塩酸塩;
2-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリミジン-5-オール二塩酸塩;
5-[1-(2H3)メチル-1H-ピラゾール-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-[1-(ジフルオロメチル)-1H-ピラゾール-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-1,2,3-トリアゾール-1-イル)フェノール塩酸塩;
5-(2-メチルピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-[2-(トリフルオロメチル)ピリジン-4-イル]フェノール二塩酸塩;
5-(ピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(ピリダジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(2-メトキシピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
6-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリダジン-3-オール塩酸塩;
6-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]キノリン-7-オール臭化水素酸塩;
4-クロロ-5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二臭化水素酸塩;
4-フルオロ-5-(ピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二臭化水素酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(チオフェン-3-イル)フェノール塩酸塩;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリジン-2(1H)-オン塩酸塩;
5-(フラン-3-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,3-チアゾール-2-イル)フェノール塩酸塩;
5-(1-メチル-1H-ピラゾール-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール二塩酸塩;
5-[1-(2H3)メチル-1H-ピラゾール-4-イル]-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール二塩酸塩;
5-[5-(ジフルオロメトキシ)ピリジン-2-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノールギ酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチル-1,2,3,6-テトラヒドロピリジン-4-イル)フロ[3,2-c]ピリダジン-3-イル]フェノール塩酸塩;
5-(3-フルオロ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,3-チアゾール-5-イル)フェノール塩酸塩;
5-(3-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1H-ピラゾール-3-カルボニトリル塩酸塩;
2-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1,3-チアゾール-5-カルボニトリル塩酸塩;
5-(1,3-オキサゾール-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノールギ酸塩;
5-[2-(ジフルオロメトキシ)ピリジン-4-イル]-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,3,4-チアジアゾール-2-イル)フェノール塩酸塩;
6-[4-(1H-ピラゾール-4-イル)-1H-ベンゾトリアゾール-7-イル]-3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジントリフルオロ酢酸塩;
5-(1H-ピロロ[2,3-b]ピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(2-メトキシピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(1,2-オキサゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(5-フルオロ-1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(1-エチル-5-フルオロ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(2-エトキシピリジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(6-エトキシピリミジン-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-([1,2,3]トリアゾロ[1,5-a]ピリジン-5-イル)フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-([1,2,4]トリアゾロ[1,5-a]ピリジン-7-イル)フェノール塩酸塩;
5-(3-クロロ-1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
6-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}ピリミジン-4(3H)-オン塩酸塩;
5-(3-クロロ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(3-フルオロ-1-メチル-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(3-メトキシ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
4-{3-ヒドロキシ-4-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェニル}-1-メチル-1H-ピラゾール-3-カルボニトリル塩酸塩;
5-(5-メチル-1,3-チアゾール-2-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1,2,4-チアジアゾール-5-イル)フェノール塩酸塩;
5-(4-フルオロ-1H-ベンゾトリアゾール-6-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-ピロロ[2,3-c]ピリダジン-3-イル]ピリジン-3-オール二塩酸塩;
5-(3-ブロモ-1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(1-メチル-1H-1,2,3-トリアゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-[3-(トリフルオロメチル)-1H-ピラゾール-4-イル]フェノール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]ピリジン-3-オール塩酸塩;
5-(1H-ピラゾール-4-イル)-2-[7-(2,2,6,6-テトラメチルピペリジン-4-イル)-7H-イミダゾ[4,5-c]ピリダジン-3-イル]ピリジン-3-オール二塩酸塩;
5-(イミダゾ[1,2-a]ピラジン-6-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(4-フルオロ-1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(4-メチル-1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-[1,2,3]トリアゾロ[4,5-b]ピリジン-6-イル)フェノール二塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(3H-[1,2,3]トリアゾロ[4,5-c]ピリジン-6-イル)フェノール二塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(1H-[1,2,3]トリアゾロ[4,5-b]ピリジン-5-イル)フェノール二塩酸塩;
5-(2,4-ジメチル-1H-イミダゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(2-メチル-1,3-チアゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(2-メチル-2H-1,2,3-トリアゾール-4-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-([1,2,4]トリアゾロ[4,3-b]ピリダジン-6-イル)フェノール塩酸塩;
5-(3-メチル-1,2,4-チアジアゾール-5-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール塩酸塩;
5-(5-メチル-1H-ピラゾール-1-イル)-2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]フェノール二塩酸塩;
5-(3-メチル-1H-ピラゾール-1-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール二塩酸塩;
5-(4-メトキシ-1,3,5-トリアジン-2-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール二塩酸塩;
5-(イミダゾ[1,2-a]ピリミジン-6-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール塩酸塩;
5-(3-フルオロ-1H-ピラゾール-4-イル)-2-(1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル)フェノール塩酸塩;
5-(イミダゾ[1,2-b]ピリダジン-6-イル)-2-(3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル)フェノール塩酸塩;
2-[3-(2,2,6,6-テトラメチルピペリジン-4-イル)-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル]-5-(2H-1,2,3-トリアゾール-2-イル)フェノール塩酸塩;
2-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール二塩酸塩;
5-(ピリジン-4-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール塩酸塩;
5-(ピリジン-3-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール塩酸塩;
5-(ピリミジン-5-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール塩酸塩;
2-{3-[(3S,4R)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール二塩酸塩;
5-(1-メチル-1H-ピラゾール-3-イル)-2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]フェノール塩酸塩;
2-{3-[3-(tert-ブチルアミノ)シクロブチル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール二塩酸塩;
4-(4-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-3-ヒドロキシフェニル)-1-メチルピリジン-2(1H)-オン塩酸塩;
6-(4-{3-[(3S,4S)-3-フルオロ-2,2,6,6-テトラメチルピペリジン-4-イル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-3-ヒドロキシフェニル)-3-メチルピリミジン-4(3H)-オン二塩酸塩;
2-[1-(2,2,6,6-テトラメチルピペリジン-4-イル)-1H-ピラゾロ[3,4-c]ピリダジン-5-イル]-5-(2H-1,2,3-トリアゾール-2-イル)フェノール塩酸塩;および
2-{3-[3-(tert-ブチルアミノ)シクロペンチル]-3H-[1,2,3]トリアゾロ[4,5-c]ピリダジン-6-イル}-5-(1H-ピラゾール-4-イル)フェノール二塩酸塩;
からなる群から選択される請求項6に記載の化合物塩、またはその形態であって、化合物の形態が、その水和物、溶媒和物、ラセミ化合物、鏡像異性体、ジアステレオ異性体、立体異性体および互変異性体形態からなる群から選択される、化合物塩。 5- (1H-Pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-imidazole [4,5-b] pyrazine-5-yl ] Phenolic hydrochloride;
5- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-imidazole [4,5 -B] Pyrazine hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl ] Phenolic hydrochloride;
3- [2,5-difluoro-4- (1H-pyrazol-4-yl) phenyl] -7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5 -C] Pyridazine hydrochloride;
2- [6-Methyl-7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenolic hydrochloride;
3- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -6-methyl-7- (2,2,6,6-tetramethylpyridazine-4-yl) -7H-imidazole [4,5-c] pyridazine hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Phenolic hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [5- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) -5H-pyrrolo [2] , 3-b] Pyrazine-2-yl] Phenolic hydrochloride;
3- [2-Hydroxy-4- (1H-pyrazole-4-yl) phenyl] -7- (2,2,6,6-tetramethylpyridazine-4-yl) -7H-imidazole [4,5-c ] Pyridazine-6-all hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [5- (2,2,6,6-tetramethylpiperidine-4-yl) -5H-pyrolo [2,3-b] pyrazine-2-yl ] Phenolic hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (1,2,3,6-tetrahydropyridine-4-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] Phenolic hydrochloride;
2- [7- (Piperidine-4-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) phenol hydrochloride;
6- [2,3-difluoro-4- (1H-pyrazole-4-yl) phenyl] -3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine hydrochloride;
6- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (1,2,3,6-tetrahydropyridine-4-yl) thieno [3,2-c] pyridazine-3-yl] phenol hydrochloride ;
2- [2,5-difluoro-4- (1H-pyrazole-4-yl) phenyl] -5- (2,2,6,6-tetramethylpiperidine-4-yl) -5H-pyrrolo [2,3 -B] Pyrazine hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) Thieno [3,2- c] Pyridazine-3-yl] Phenolic hydrochloride;
2- [7- (8-azabicyclo [3.2.1] octa-2-en-3-yl) thieno [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) Il) Phenolic hydrochloride;
2- [1- (Piperidin-4-yl) -1H-pyrazolo [3,4-b] pyrazine-5-yl] -5- (1H-pyrazole-4-yl) phenol hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) -5H-pyrrolo [3 , 2-c] pyridazine-3-yl] phenol hydrochloride;
2- [1- (Piperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] -5- (1H-pyrazole-4-yl) phenol hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl ] Phenolic hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) -6,7-dihydro-5H-pyrrolo [2,3-c] ] Pyridazine-3-yl] Phenolic hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) thieno [3,2-c] pyridazine-3-yl] phenol hydrochloride salt;
2- [7- (3-oxa-9-azabicyclo [3.3.1] nona-6-en-7-yl) thieno [3,2-c] pyridazine-3-yl] -5- (1H-) Pyrazole-4-yl) phenol hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-pyrolo [2,3-c] pyridazine-3-yl ] Phenolic hydrochloride;
2- [7- (8-azabicyclo [3.2.1] octa-2-en-3-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenolic hydrochloride;
2- [7- (3-oxa-9-azabicyclo [3.3.1] nona-6-en-7-yl) -5H-pyrolo [3,2-c] pyridazine-3-yl] -5 (1H-pyrazole-4-yl) phenol hydrochloride;
2- [7- (8-azabicyclo [3.2.1] octa-3-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole-4-yl) ) Phenolic hydrochloride;
2- [7- (3-oxa-9-azabicyclo [3.3.1] nona-7-yl) -5H-pyrrolo [3,2-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenolic hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidin-4-yl) -5H-pyrolo [3,2-c] pyridazine-3-yl ] Phenolic hydrochloride;
3- [2,3-difluoro-4- (1H-pyrazole-4-yl) phenyl] -7- (2,2,6,6-tetramethylpyridazine-4-yl) -6,7-dihydro-5H -Pyrolo [2,3-c] pyridazine hydrochloride;
4-Fluoro-2- (1H-pyrazole-4-yl) -5- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrochloride;
4-Fluoro-5- (1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrobromide;
7-[(3-exo) -8-azabicyclo [3.2.1] octa-3-yl] -3- [2,3-difluoro-4- (1H-pyrazole-4-yl) phenyl] -6 , 7-Dihydro-5H-pyrrolo [2,3-c] pyridazine hydrochloride;
4- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] biphenyl-3, 4'-diol hydrobromide;
5- (1-Methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrobromide;
2- [6-Methoxy-7- (2,2,6,6-tetramethylpiperidin-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5- (1H-pyrazole) -4-yl) Phenolic hydrochloride;
2- [6- (Methylamino) -7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5-( 1H-pyrazole-4-yl) phenol hydrochloride;
2- [6- (Ethylamino) -7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl] -5-( 1H-pyrazole-4-yl) phenol hydrochloride;
2- [3- (1,2,2,6,6-pentamethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5 -(1H-pyrazole-4-yl) phenol dihydrochloride;
6-Fluoro-4- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] [1,1'-biphenyl] -3,4'-diol hydrobromide;
2-Fluoro-3- (1H-pyrazole-4-yl) -6- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol dihydrochloride;
4- {2-Fluoro-5-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] ] Pyridazine-6-yl] Phenyl} -1-methylpyridine-2 (1H) -one hydrochloride;
2- [3- (2,2-Dimethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5- (1H-pyrazole-4) -Il) Phenolic hydrochloride;
2- {3-[(1R, 5S) -1,5-dimethyl-8-azabicyclo [3.2.1] octane-3-yl] -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl} -5- (1H-pyrazole-4-yl) phenol hydrochloride;
2- (1H-Pyrazole-4-yl) -5- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-] c] Pyridazine-6-yl] benzene-1,4-diol dihydrochloride;
3-Fluoro-5- (1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol dihydrochloride;
5- (Pyrazine-2-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol dichloride;
5- (Pyridine-2-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol dichloride;
4-Fluoro-5- (1-Methyl-1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H-1,2,4-triazole-1-yl) phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 4H-1,2,4-triazole-4-yl) phenol hydrochloride;
5- (Pyridine-3-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol dichloride;
5- (Pyridine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol dichloride;
6- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyridine-3-ol dihydrochloride;
2- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyrimidine-5-all dihydrochloride;
5- [1- (2H 3 ) Methyl - 1H-Pyrazole-4-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2 , 3] Triazolo [4,5-c] pyridazine-6-yl] phenol dihydrochloride;
5- (1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-] c] Pyridazine-6-yl] Phenolic hydrochloride;
5- [1- (difluoromethyl) -1H-pyrazole-4-yl] -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3 ] Triazolo [4,5-c] pyridazine-6-yl] phenol dihydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H-1,2,3-triazole-1-yl) phenol hydrochloride;
5- (2-Methylpyridine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl] Phenolic hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-[ 2- (Trifluoromethyl) Pyridine-4-yl] Phenolic Dihydrochloride;
5- (Pyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyrimidine-6-yl] phenol dichloride;
5- (Pyridazine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol hydrochloride;
5- (2-Methoxypyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl] Phenolic dihydrochloride;
6- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] phenyl} pyridazine-3-all hydrochloride;
6- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] quinoline-7- All hydrobromide;
4-Chloro-5- (1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol hydrobromide;
4-Fluoro-5- (pyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4, 5-c] Pyridazine-6-yl] Phenol hydrobromide;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( Thiophene-3-yl) phenol hydrochloride;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} Pyridine-2 (1H) -on hydrochloride;
5- (Fran-3-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl] phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,3-thiazole-2-yl) phenol hydrochloride;
5- (1-Methyl-1H-pyrazole-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine -5-Il] Phenolic dihydrochloride;
5- [1- (2H 3 ) Methyl - 1H-pyrazole-4-yl] -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3, 4-c] pyridazine-5-yl] phenol dihydrochloride;
5- [5- (difluoromethoxy) Pyridine-2-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenol formate;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-4-yl) flow [3,2- c] Pyridazine-3-yl] Phenolic hydrochloride;
5- (3-Fluoro-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,3-thiazole-5-yl) phenol hydrochloride;
5- (3-Methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrochloride;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] phenyl} -1H-pyrazole-3-carbonitrile hydrochloride;
2- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} -1,3-thiazole-5-carbonitrile hydrochloride;
5- (1,3-Oxazole-2-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4, 5-c] pyridazine-6-yl] phenol formate;
5- [2- (Difluoromethoxy) Pyridine-4-yl] -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenolic hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,3,4-Thiadiazole-2-yl) Phenolic hydrochloride;
6- [4- (1H-Pyrazole-4-yl) -1H-benzotriazole-7-yl] -3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazoro [4,5-c] pyridazine trifluoroacetate ;
5- (1H-pyrrolo [2,3-b] pyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (2-Methoxypyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5] -C] Pyrimidine-6-yl] Phenolic hydrochloride;
5- (1,2-oxazol-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4, 5-c] pyridazine-6-yl] phenol hydrochloride;
5- (5-Fluoro-1-methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (1-Ethyl-5-fluoro-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (2-ethoxypyridin-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5] -C] Pyridazine-6-yl] Phenolic hydrochloride;
5- (6-ethoxypyrimidine-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5 -C] Pyrimidine-6-yl] Phenolic hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( [1,2,3] Triazolo [1,5-a] Pyridine-5-yl) Phenolic hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( [1,2,4] Triazolo [1,5-a] Pyridine-7-yl) Phenolic hydrochloride;
5- (3-Chloro-1-methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
6- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} pyrimidine-4 (3H) -on hydrochloride;
5- (3-Chloro-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (3-Fluoro-1-methyl-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (3-Methoxy-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrochloride;
4- {3-Hydroxy-4- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6 -Il] Phenyl} -1-Methyl-1H-Pyrazole-3-Carbonitrile Hydrochloride;
5- (5-Methyl-1,3-thiazole-2-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1,2,4-Thiadiazole-5-yl) Phenolic hydrochloride;
5- (4-Fluoro-1H-benzotriazole-6-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-pyrrolo [2,3-c] pyridazine-3-yl ] Pyridine-3-ol dihydrochloride;
5- (3-bromo-1H-pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (1-Methyl-1H-1,2,3-triazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-[ 3- (Trifluoromethyl) -1H-pyrazole-4-yl] phenol hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [4,5- c] Pyridazine-6-yl] Pyridine-3-ol hydrochloride;
5- (1H-Pyrazole-4-yl) -2- [7- (2,2,6,6-tetramethylpiperidine-4-yl) -7H-imidazole [4,5-c] pyridazine-3-yl ] Pyridine-3-ol dihydrochloride;
5- (Imidazo [1,2-a] pyrazine-6-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (4-Fluoro-1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenolic dihydrochloride;
5- (4-Methyl-1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl] Phenolic dihydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H- [1,2,3] triazolo [4,5-b] pyridin-6-yl) phenol dihydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 3H- [1,2,3] triazolo [4,5-c] pyridin-6-yl) phenol dihydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 1H- [1,2,3] triazolo [4,5-b] pyridin-5-yl) phenol dihydrochloride;
5- (2,4-dimethyl-1H-imidazol-1-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol dichloride;
5- (2-Methyl-1,3-thiazole-5-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol dichloride;
5- (2-Methyl-2H-1,2,3-triazole-4-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1, 2,3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( [1,2,4] triazolo [4,3-b] pyridazine-6-yl) phenol hydrochloride;
5- (3-Methyl-1,2,4-thiadiazole-5-yl) -2- [3- (2,2,6,6-tetramethylpyridazine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl] phenol hydrochloride;
5- (5-Methyl-1H-pyrazole-1-yl) -2- [3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] pyridazine-6-yl] phenol dihydrochloride;
5- (3-Methyl-1H-pyrazole-1-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] triazolo [ 4,5-c] Pyridazine-6-yl) Phenol dihydrochloride;
5- (4-Methoxy-1,3,5-triazine-2-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2, 3] Triazolo [4,5-c] pyridazine-6-yl) phenol dihydrochloride;
5- (Imidazo [1,2-a] pyrimidin-6-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl) phenol hydrochloride;
5- (3-Fluoro-1H-pyrazole-4-yl) -2- (1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine -5-yl) Phenolic hydrochloride;
5- (Imidazo [1,2-b] pyridazine-6-yl) -2- (3- (2,2,6,6-tetramethylpiperidine-4-yl) -3H- [1,2,3] Triazolo [4,5-c] pyridazine-6-yl) phenol hydrochloride;
2- [3- (2,2,6,6-tetramethylpiperidin-4-yl) -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl] -5-( 2H-1,2,3-triazole-2-yl) phenol hydrochloride;
2- {3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl} -5- (1H-pyrazole-4-yl) phenol dihydrochloride;
5- (Pyridine-4-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] phenol Hydrochloride;
5- (Pyridine-3-yl) -2- [1- (2,2,6,6-tetramethylpiperidine-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] phenol Hydrochloride;
5- (Pyrimidine-5-yl) -2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] phenol Hydrochloride;
2- {3-[(3S, 4R) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H- [1,2,3] triazolo [4,5-c] Pyridazine-6-yl} -5- (1H-pyrazole-4-yl) phenol dihydrochloride;
5- (1-Methyl-1H-pyrazole-3-yl) -2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine -5-Il] Phenolic hydrochloride;
2- {3- [3- (tert-butylamino) cyclobutyl] -3H- [1,2,3] triazolo [4,5-c] pyridazine-6-yl} -5- (1H-pyrazole-4-) Il) Phenol dihydrochloride;
4- (4- {3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpiperidine-4-yl] -3H- [1,2,3] triazolo [4,5 -C] Pyridazine-6-yl} -3-hydroxyphenyl) -1-methylpyridine-2 (1H) -one hydrochloride;
6- (4- {3-[(3S, 4S) -3-fluoro-2,2,6,6-tetramethylpyridazine-4-yl] -3H- [1,2,3] triazolo [4,5] -C] Pyridazine-6-yl} -3-hydroxyphenyl) -3-methylpyrimidine-4 (3H) -one dihydrochloride;
2- [1- (2,2,6,6-tetramethylpiperidin-4-yl) -1H-pyrazolo [3,4-c] pyridazine-5-yl] -5- (2H-1,2,3) -Triazole-2-yl) phenol hydrochloride; and 2- {3- [3- (tert-butylamino) cyclopentyl] -3H- [1,2,3] triazolo [4,5-c] pyridazine-6- Il} -5- (1H-pyrazole-4-yl) phenol dihydrochloride;
The compound salt according to claim 6 selected from the group consisting of , or a form thereof, wherein the form of the compound is its hydrate, solvate, racemic compound, enantiomer, diastereoisomer, stereo. A compound salt selected from the group consisting of isomers and tautomeric forms.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862690653P | 2018-06-27 | 2018-06-27 | |
US62/690,653 | 2018-06-27 | ||
PCT/US2019/038889 WO2020005873A1 (en) | 2018-06-27 | 2019-06-25 | Heterocyclic and heteroaryl compounds for treating huntington's disease |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021528467A JP2021528467A (en) | 2021-10-21 |
JPWO2020005873A5 true JPWO2020005873A5 (en) | 2022-06-21 |
JP7421507B2 JP7421507B2 (en) | 2024-01-24 |
Family
ID=67180896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020572895A Active JP7421507B2 (en) | 2018-06-27 | 2019-06-25 | Heterocyclic and heteroaryl compounds for treating Huntington's disease |
Country Status (17)
Country | Link |
---|---|
US (1) | US11858941B2 (en) |
EP (1) | EP3814357B1 (en) |
JP (1) | JP7421507B2 (en) |
KR (1) | KR20210042265A (en) |
CN (1) | CN112654625A (en) |
AR (1) | AR119651A1 (en) |
AU (2) | AU2019294478B2 (en) |
BR (1) | BR112020026545A2 (en) |
CA (1) | CA3103976A1 (en) |
CL (3) | CL2020003378A1 (en) |
CO (1) | CO2020016285A2 (en) |
EA (1) | EA202092896A1 (en) |
IL (1) | IL279688A (en) |
MX (1) | MX2020014098A (en) |
PE (1) | PE20211378A1 (en) |
SG (1) | SG11202012674PA (en) |
WO (1) | WO2020005873A1 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017100726A1 (en) | 2015-12-10 | 2017-06-15 | Ptc Therapeutics, Inc. | Methods for treatng huntington's disease |
AU2018282154B2 (en) | 2017-06-05 | 2022-04-07 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
WO2019005980A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
AU2018309187C1 (en) | 2017-08-04 | 2023-09-07 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
MX2020006587A (en) | 2017-12-22 | 2020-12-10 | Ravenna Pharmaceuticals Inc | Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors. |
SG11202009212WA (en) | 2018-03-27 | 2020-10-29 | Ptc Therapeutics Inc | Compounds for treating huntington's disease |
KR20210042265A (en) | 2018-06-27 | 2021-04-19 | 피티씨 테라퓨틱스, 인크. | Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease |
EP3814360A1 (en) | 2018-06-27 | 2021-05-05 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
JP2022521467A (en) | 2019-02-05 | 2022-04-08 | スカイホーク・セラピューティクス・インコーポレーテッド | Methods and compositions for regulating splicing |
JP2022519323A (en) | 2019-02-06 | 2022-03-22 | スカイホーク・セラピューティクス・インコーポレーテッド | Methods and compositions for regulating splicing |
CN113840602A (en) * | 2019-03-15 | 2021-12-24 | 斯基霍克疗法公司 | Compositions and methods for correcting aberrant splicing |
JP2022533120A (en) * | 2019-05-13 | 2022-07-21 | ピーティーシー セラピューティクス, インコーポレイテッド | Compounds for treating Huntington's disease |
US11129829B2 (en) | 2019-06-17 | 2021-09-28 | Skyhawk Therapeutics, Inc. | Methods for modulating splicing |
CN114650822A (en) * | 2019-11-01 | 2022-06-21 | 诺华股份有限公司 | Use of splice modulators for treatment of slowing progression of huntington's disease |
JP2023532623A (en) | 2020-05-13 | 2023-07-31 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | HTT modulators for treating Huntington's disease |
AU2021300260A1 (en) | 2020-07-02 | 2023-02-09 | Remix Therapeutics Inc. | 5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases |
US20240002375A1 (en) | 2020-07-02 | 2024-01-04 | Remix Therapeutics Inc. | 2-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the tre |
WO2022060951A1 (en) * | 2020-09-16 | 2022-03-24 | Skyhawk Therapeutics, Inc. | Compositions for modulating splicing |
WO2022060943A1 (en) * | 2020-09-16 | 2022-03-24 | Skyhawk Therapeutics, Inc. | Compositions for modulating splicing |
WO2022060944A1 (en) * | 2020-09-16 | 2022-03-24 | Skyhawk Therapeutics, Inc. | Compositions for modulating splicing |
MX2023005541A (en) | 2020-11-12 | 2023-06-15 | Ptc Therapeutics Inc | Novel rna transcript. |
CA3196747A1 (en) | 2020-11-13 | 2022-05-19 | Swathi PINNAMANENI | Tablet for use in treating huntington's disease and method of making the same |
EP4308572A1 (en) * | 2021-03-17 | 2024-01-24 | F. Hoffmann-La Roche AG | New thienopyrimidinone derivatives |
TW202304446A (en) | 2021-03-29 | 2023-02-01 | 瑞士商諾華公司 | The use of a splicing modulator for a treatment slowing progression of huntington’s disease |
AU2022320725A1 (en) | 2021-07-30 | 2024-02-22 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
WO2023081860A1 (en) * | 2021-11-04 | 2023-05-11 | Skyhawk Therapeutics, Inc. | Triazine amino derivatives for treating sca3 |
WO2023220134A1 (en) * | 2022-05-10 | 2023-11-16 | Foghorn Therapeutics Inc. | Pyrazine derivatives and uses thereof |
WO2023244996A2 (en) * | 2022-06-15 | 2023-12-21 | Ptc Therapeutics, Inc. | Heterocyclic and heteroaryl compounds for treating huntington's disease |
Family Cites Families (194)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE637271A (en) | 1963-04-04 | 1900-01-01 | ||
US3558618A (en) | 1968-04-01 | 1971-01-26 | Dow Chemical Co | Novel 4h-pyrazino(1,2-a)pyrimidine-4-ones |
GB1383409A (en) | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
US4122274A (en) | 1977-05-25 | 1978-10-24 | Bristol-Myers Company | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
US4342870A (en) | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
JPS56150091A (en) | 1980-03-28 | 1981-11-20 | Janssen Pharmaceutica Nv | 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture |
FR2567518B1 (en) | 1984-07-11 | 1987-11-13 | Sanofi Sa | NOVEL NITROGEN HETEROCYCLIC CORE COMPOUNDS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THE SAME |
US5089633A (en) | 1987-04-28 | 1992-02-18 | Georgia Tech Research Corporation | Substituted isocoumarins |
US5726182A (en) | 1990-05-02 | 1998-03-10 | Abbott Laboratories | Quinolizinone type compounds |
WO1993023398A1 (en) | 1992-05-13 | 1993-11-25 | E.I. Du Pont De Nemours And Company | Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides |
DE69435005T2 (en) | 1993-05-11 | 2008-04-17 | The University Of North Carolina At Chapel Hill | Antisense oligonucleotides that prevent abnormal splicing and their use |
CA2222322A1 (en) | 1995-06-06 | 1996-12-12 | Abbott Laboratories | Quinolizinone type compounds |
US5916916A (en) | 1996-10-10 | 1999-06-29 | Eli Lilly And Company | 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
US5869500A (en) | 1996-12-13 | 1999-02-09 | Hoffmann-La Roche Inc. | Pyridone compounds useful in treating Alzheimer's disease |
CA2269561C (en) | 1998-04-22 | 2007-06-05 | Dainippon Ink And Chemicals, Inc. | Naphthalene derivative and liquid crystal composition comprising the same |
US6630488B1 (en) | 1998-09-21 | 2003-10-07 | Biochem Pharma, Inc. | Quinolizinones as integrin inhibitors |
US6172216B1 (en) | 1998-10-07 | 2001-01-09 | Isis Pharmaceuticals Inc. | Antisense modulation of BCL-X expression |
US6214986B1 (en) | 1998-10-07 | 2001-04-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of bcl-x expression |
US6210892B1 (en) | 1998-10-07 | 2001-04-03 | Isis Pharmaceuticals, Inc. | Alteration of cellular behavior by antisense modulation of mRNA processing |
ATE312820T1 (en) | 1999-10-28 | 2005-12-15 | Trine Pharmaceuticals Inc | PUMP INHIBITORS FOR DRUG RELEASE |
PT1257537E (en) | 2000-01-24 | 2007-08-03 | Astrazeneca Ab | Therapeutic morpholino-substituted compounds |
US20050054836A1 (en) | 2000-11-09 | 2005-03-10 | Cold Spring Harbor Laboratory | Chimeric molecules to modulate gene expression |
US6774134B2 (en) | 2000-12-20 | 2004-08-10 | Bristol-Myers Squibb Company | Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
KR100947185B1 (en) | 2000-12-21 | 2010-03-15 | 버텍스 파마슈티칼스 인코포레이티드 | Pyrazole compounds useful as protein kinase inhibitors and compositions comprising said compounds |
GB0100624D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds VII |
WO2002087589A1 (en) | 2001-04-26 | 2002-11-07 | Daiichi Pharmaceutical Co., Ltd. | Medicine for inhibiting drug elimination pump |
EP1474147B1 (en) | 2001-12-07 | 2010-05-05 | Vertex Pharmaceuticals Incorporated | Pyrimidine-based compounds useful as gsk-3 inhibitors |
GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
WO2004009558A2 (en) | 2002-07-24 | 2004-01-29 | Ptc Therapeutics, Inc. | Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
AU2003262833A1 (en) | 2002-08-23 | 2004-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Fluorescent glycosides and methods for their use |
US7220741B2 (en) | 2002-09-30 | 2007-05-22 | Neurosearch A/S | 1,4-diazabicycloalkane derivatives, their preparation and use |
US20070078144A1 (en) | 2003-01-29 | 2007-04-05 | Stockwell Brent R | Agents for treating neurodegenerative diseases |
PT1636225E (en) | 2003-06-20 | 2010-05-03 | Novartis Vaccines & Diagnostic | Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents |
GB0315494D0 (en) | 2003-07-02 | 2003-08-06 | Biofocus Plc | Compounds which bind to the active site of protein kinase enzymes |
RU2355687C2 (en) | 2003-08-01 | 2009-05-20 | Дженелэбс Текнолоджиз, Инк | Bicyclic imidazol derivatives as medium against viruses of flaviviridae family |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
US20050074801A1 (en) | 2003-09-09 | 2005-04-07 | Monia Brett P. | Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
US20050137203A1 (en) | 2003-12-22 | 2005-06-23 | Jianguo Ji | 3-quinuclidinyl amino-substituted biaryl derivatives |
US7309699B2 (en) | 2003-12-22 | 2007-12-18 | Abbott Laboratories | 3-Quinuclidinyl amino-substituted biaryl derivatives |
US20050245531A1 (en) | 2003-12-22 | 2005-11-03 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
US7655657B2 (en) | 2003-12-22 | 2010-02-02 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
NZ551468A (en) | 2003-12-24 | 2010-05-28 | Biota Scient Management | Polycyclic agents for the treatment of respiratory syncytial virus infections |
SE0400184D0 (en) | 2004-01-30 | 2004-01-30 | Fyrkloevern Scandinavia Ab | New therapeutic use |
TW200536830A (en) | 2004-02-06 | 2005-11-16 | Chugai Pharmaceutical Co Ltd | 1-(2H)-isoquinolone derivative |
CA2557852A1 (en) | 2004-04-08 | 2005-10-27 | Neurogen Corporation | Substituted cinnolin-4-ylamines |
CA2563669A1 (en) | 2004-05-04 | 2005-11-10 | Warner-Lambert Company Llc | Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents |
EP1846397A1 (en) | 2005-01-21 | 2007-10-24 | Janssen Pharmaceutica N.V. | Novel heterocyclic benzoy[c]chromene derivatives useful as modulators of the estrogen receptors |
US7879992B2 (en) | 2005-01-31 | 2011-02-01 | Isis Pharmaceuticals, Inc. | Modification of MyD88 splicing using modified oligonucleotides |
GB0501999D0 (en) | 2005-02-01 | 2005-03-09 | Sentinel Oncology Ltd | Pharmaceutical compounds |
JP2006219453A (en) | 2005-02-14 | 2006-08-24 | Tokyo Univ Of Pharmacy & Life Science | Metal-discrimination-type two-color fluorescent molecule containing quinoline ring as parent nucleus |
US7563601B1 (en) | 2005-06-01 | 2009-07-21 | City Of Hope | Artificial riboswitch for controlling pre-mRNA splicing |
WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
ES2375929T3 (en) | 2005-07-04 | 2012-03-07 | High Point Pharmaceuticals, Llc | HISTAMINE RECEIVER ANTAGONISTS H3. |
US7473784B2 (en) | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
US8258109B2 (en) | 2005-10-20 | 2012-09-04 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of LMNA expression |
AU2006315758A1 (en) | 2005-11-10 | 2007-05-24 | Ercole Biotech, Inc. | Splice switching oligomers for TNF superfamily receptors and their use in treatment of disease |
NZ567048A (en) | 2005-12-06 | 2010-12-24 | Neurosearch As | Novel diazabicyclic aryl derivatives and their medical use |
CN101360738A (en) | 2005-12-21 | 2009-02-04 | 佩因赛普托药物公司 | Compositions and methods for modulating gated ion channels |
JP5425474B2 (en) | 2006-01-26 | 2014-02-26 | アイシス ファーマシューティカルズ, インコーポレーテッド | Composition and use thereof for huntingtin |
US8129515B2 (en) | 2006-01-27 | 2012-03-06 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for the use in modulation of microRNAs |
AR059339A1 (en) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | CUMARINE DERIVATIVES FOR PROLIFERATIVE DISORDERS OF CELLS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT CONTAINING THEM |
US8110681B2 (en) | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
CN101410385B (en) | 2006-03-28 | 2011-08-24 | 高点制药有限责任公司 | Benzothiazoles having histamine H3 receptor activity |
WO2007130383A2 (en) | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
US20080247964A1 (en) | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
TW200812588A (en) * | 2006-05-15 | 2008-03-16 | Neurogen Corp | CRF1 receptor ligands comprising heteroaryl fused bicycles |
US7910578B2 (en) | 2006-05-23 | 2011-03-22 | Neurosearch A/S | 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use |
CA2658462C (en) | 2006-07-20 | 2011-09-27 | Amgen Inc. | Substituted pyridone compounds and methods of use |
WO2008013997A2 (en) | 2006-07-27 | 2008-01-31 | The Trustees Of Columbia University In The City Of New York | Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
PT2066653E (en) | 2006-08-03 | 2012-10-22 | Rottapharm Spa | 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
MX2009003892A (en) | 2006-10-25 | 2009-04-23 | Neurosearch As | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators. |
US8314119B2 (en) | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
DK2114903T3 (en) | 2006-12-22 | 2011-04-18 | Avexa Ltd | Bicyclic pyrimidinones and their applications |
US20080171792A1 (en) | 2006-12-28 | 2008-07-17 | Jobdevairakkam Christopher New | Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders |
FR2914188B1 (en) | 2007-03-28 | 2012-06-22 | Trophos | NEW CHOLEST-4-EN-3-ONE OXIME COMPOSITION |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
HUE025976T2 (en) | 2007-09-27 | 2016-05-30 | Fund Centro Nac De Investig Oncologicas Carlos Iii | Imidazolothiadiazoles for use as protein kinase inhibitors |
EP2573080A1 (en) | 2007-09-27 | 2013-03-27 | The United States of America, as Represented by the Secretary, Department of Health and Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
US8153813B2 (en) | 2007-12-20 | 2012-04-10 | Abbott Laboratories | Benzothiazole and benzooxazole derivatives and methods of use |
WO2009114874A2 (en) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Benzothiazole kinase inhibitors and methods of use |
WO2009126635A1 (en) | 2008-04-09 | 2009-10-15 | Abbott Laboratories | 2-amino-benzothiazole derivates useful as inhibitors of rock kinases |
WO2009131958A2 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising triazine derivatives |
WO2009151546A2 (en) | 2008-05-27 | 2009-12-17 | Ptc Therapeutics, Inc. | Methods for treating spinal muscular atrophy |
PT2315588E (en) | 2008-06-20 | 2013-03-25 | Rottapharm Spa | 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
EP2138493A1 (en) | 2008-06-26 | 2009-12-30 | Sanofi-Aventis | Substituted pyrimidone derivatives |
SG192452A1 (en) | 2008-07-02 | 2013-08-30 | Avexa Ltd | Compounds having antiviral properties |
US8986935B2 (en) | 2008-08-13 | 2015-03-24 | Ptc Therapeutics, Inc. | Methods for treating spinal muscular atrophy |
WO2010024903A1 (en) | 2008-08-29 | 2010-03-04 | Yangbo Feng | BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS |
WO2010045303A2 (en) | 2008-10-16 | 2010-04-22 | Schering Corporation | Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
GB2465405A (en) | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
WO2010071819A1 (en) | 2008-12-19 | 2010-06-24 | Schering Corporation | Bicyclic heterocyclic derivatives and methods of use thereof |
BRPI1008020A2 (en) | 2009-02-11 | 2016-03-15 | Sunovion Pharmaceuticals Inc | histamine h3 antagonists and inverse agonists and methods of using them |
FR2945289A1 (en) | 2009-05-11 | 2010-11-12 | Sanofi Aventis | 2-CYCLOAMINO-5- (PYRIDIN-4-YL) IMIDAZO-2,1-B1 DERIVATIVES 1,3,4! THIADIAZOLE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
EP2443122B1 (en) | 2009-06-19 | 2014-03-05 | AbbVie Inc. | Diazahomoadamantane derivatives and methods of use thereof |
SI2475675T1 (en) | 2009-09-11 | 2017-03-31 | Ionis Pharmaceuticals, Inc. | Modulation of huntingtin expression |
WO2011050245A1 (en) | 2009-10-23 | 2011-04-28 | Yangbo Feng | Bicyclic heteroaryls as kinase inhibitors |
WO2011057204A2 (en) | 2009-11-06 | 2011-05-12 | The Johns Hopkins University | Lrrk2-mediated neuronal toxicity |
US8754220B2 (en) | 2009-11-20 | 2014-06-17 | Merck Sharp & Dohme Corp. | Quinolizidinone carboxamide M1 receptor positive allosteric modulators |
AU2011206761A1 (en) | 2010-01-13 | 2012-07-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anti - infective pyrido (1,2 -a) pyrimidines |
EP2534262B1 (en) | 2010-02-08 | 2016-12-14 | Ionis Pharmaceuticals, Inc. | Selective reduction of allelic variants |
ES2733708T3 (en) | 2010-02-08 | 2019-12-02 | Ionis Pharmaceuticals Inc | Selective reduction of allelic variants |
EP2536738A4 (en) | 2010-02-08 | 2014-09-17 | Isis Pharmaceuticals Inc | Methods and compositions useful in treatment of diseases or conditions related to repeat expansion |
US8877707B2 (en) | 2010-05-24 | 2014-11-04 | Presidio Pharmaceuticals, Inc. | Inhibitors of HCV NS5A |
WO2012012443A2 (en) | 2010-07-19 | 2012-01-26 | Bennett C Frank | Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
WO2012019106A2 (en) | 2010-08-06 | 2012-02-09 | Board Of Regents Of The University Of Nebraska | Positive and negative modulators of nmda receptors |
WO2012075393A2 (en) | 2010-12-02 | 2012-06-07 | President And Fellows Of Harvard College | Activators of proteasomal degradation and uses thereof |
CN102617548A (en) * | 2011-01-31 | 2012-08-01 | 北京赛林泰医药技术有限公司 | Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof |
WO2012104823A2 (en) | 2011-02-04 | 2012-08-09 | Novartis Ag | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases |
WO2012109395A1 (en) | 2011-02-08 | 2012-08-16 | Isis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
US8703763B2 (en) | 2011-03-02 | 2014-04-22 | Hoffmann-La Roche Inc. | Bridged piperidine derivatives |
US9447075B2 (en) | 2011-08-02 | 2016-09-20 | The Brigham And Women's Hospital, Inc. | Pyridazine derivatives as EAAT2 activators |
US8871756B2 (en) | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
EP2742136B1 (en) | 2011-08-11 | 2017-09-27 | Ionis Pharmaceuticals, Inc. | Gapped oligomeric compounds comprising 5'-modified deoxyribonucleosides in the gap and uses thereof |
US20130046093A1 (en) | 2011-08-18 | 2013-02-21 | Korea Institute Of Science And Technology | Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same |
US9976138B2 (en) | 2011-08-29 | 2018-05-22 | Ionis Pharmaceuticals, Inc. | Methods and compounds useful in conditions related to repeat expansion |
WO2013059606A1 (en) | 2011-10-21 | 2013-04-25 | Tufts Medical Center, Inc. | Compounds and methods for the treatment of muscular disease, and related screening methods |
GB201119538D0 (en) | 2011-11-10 | 2011-12-21 | Viral Ltd | Pharmaceutical compounds |
MX2014006409A (en) | 2011-11-28 | 2014-07-30 | Novartis Ag | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease. |
EP2797592B1 (en) | 2011-12-30 | 2019-08-28 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
CA2862084C (en) | 2012-01-26 | 2021-05-11 | Ptc Therapeutics, Inc. | 1h-isochromen-1-one derivatives and compositions thereof for treating spinal muscular atrophy |
BR112014019750B1 (en) | 2012-02-10 | 2020-03-03 | F. Hoffmann-La Roche Ag. | COMPOUND, PHARMACEUTICAL COMPOSITION AND ITS USES |
JP6092264B2 (en) | 2012-03-01 | 2017-03-08 | ピーティーシー セラピューティクス, インコーポレイテッド | Compounds for treating spinal muscular atrophy |
CA2868026C (en) | 2012-03-23 | 2021-02-16 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
CN106977495B (en) * | 2012-04-24 | 2020-08-04 | 沃泰克斯药物股份有限公司 | DNA-PK inhibitors |
WO2014012050A2 (en) | 2012-07-13 | 2014-01-16 | Indiana University Research & Technology Corporation | Compounds for treatment of spinal muscular atrophy |
MY174339A (en) | 2012-08-13 | 2020-04-09 | Novartis Ag | 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
DK2906256T3 (en) | 2012-10-12 | 2018-11-19 | Ionis Pharmaceuticals Inc | SELECTIVE ANTISENSE COMPOUNDS AND APPLICATIONS THEREOF |
WO2014059341A2 (en) | 2012-10-12 | 2014-04-17 | Isis Pharmaceuticals, Inc. | Antisense compounds and uses thereof |
WO2014066836A1 (en) | 2012-10-25 | 2014-05-01 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
US9227976B2 (en) * | 2012-10-25 | 2016-01-05 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
JP6255711B2 (en) | 2012-11-01 | 2018-01-10 | 株式会社リコー | Electrochromic compound, electrochromic composition, and display element |
US9040712B2 (en) | 2013-01-23 | 2015-05-26 | Novartis Ag | Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions |
EP2951304B1 (en) | 2013-02-04 | 2020-07-08 | Ionis Pharmaceuticals, Inc. | Selective antisense compounds and uses thereof |
WO2014135244A1 (en) | 2013-03-05 | 2014-09-12 | Merck Patent Gmbh | Triazolo[4,5-d]pyrimidine derivatives for the treatment of diseases such as cancer |
MX2015015691A (en) | 2013-05-14 | 2016-03-04 | Hoffmann La Roche | Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection. |
MX363456B (en) | 2013-06-25 | 2019-03-25 | Hoffmann La Roche | Compounds for treating spinal muscular atrophy. |
EP4105208A1 (en) | 2013-07-31 | 2022-12-21 | Novartis AG | 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions |
MX2016001963A (en) | 2013-08-19 | 2016-05-26 | Hoffmann La Roche | Screening method. |
EP3082820B1 (en) | 2013-12-19 | 2022-07-20 | PTC Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
WO2015095446A1 (en) | 2013-12-19 | 2015-06-25 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
WO2015095449A1 (en) | 2013-12-19 | 2015-06-25 | Ptc Therapeutics, Inc. | Methods for modulating the amount rna transcripts |
EP3087067B1 (en) * | 2013-12-26 | 2018-10-24 | Takeda Pharmaceutical Company Limited | 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (magl) inhibitors |
BR112016016400A2 (en) | 2014-01-16 | 2017-10-03 | Wave Life Sciences Ltd | COMPOSITIONS OF CHIRALLY CONTROLLED OLIGONUCLEOTIDES, THEIR USE, THEIR PHARMACEUTICAL COMPOSITION, AND METHODS |
US9815813B2 (en) | 2014-01-17 | 2017-11-14 | Novartis Ag | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 |
AR099134A1 (en) | 2014-01-24 | 2016-06-29 | Hoffmann La Roche | PROCEDURE FOR THE PREPARATION OF N - [(3-AMINOOXETAN-3-IL) METHYL] -2- (1,1-DIOXO-3,5-DIHIDRO-1,4-BENZOTIAZEPÍN-4-IL) -6-METIL- QUINAZOLÍN-4-AMINA |
RU2683309C2 (en) | 2014-03-14 | 2019-03-28 | Раквалиа Фарма Инк. | Azaspiro derivatives as trpm8 antagonists |
CN106573880B (en) | 2014-03-19 | 2019-07-30 | 阿米达斯公司 | Amyloid protein targeting agent and its application method |
SI3663296T1 (en) | 2014-05-15 | 2023-08-31 | F. Hoffmann-La Roche Ag | Process for the preparation of compounds useful for treating spinal muscular atrophy |
GB201410693D0 (en) | 2014-06-16 | 2014-07-30 | Univ Southampton | Splicing modulation |
CN106573811A (en) | 2014-06-17 | 2017-04-19 | 诺维信公司 | Biological phosphorus removal from wastewater |
MX2016015248A (en) | 2014-06-25 | 2017-02-23 | Hoffmann La Roche | Imidazo[1,2-a]pyrazin-1yl-benzamide compounds for treating spinal muscular atrophy. |
JP2018500302A (en) | 2014-12-02 | 2018-01-11 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | Bicyclic compounds as pest control agents |
SI3237618T1 (en) | 2014-12-24 | 2019-09-30 | Uniqure Ip B.V. | Rnai induced huntingtin gene suppression |
EA037663B1 (en) | 2015-01-16 | 2021-04-28 | Те Дженерал Хоспитал Корпорейшн | COMPOUNDS FOR IMPROVING mRNA SPLICING |
CN107428729B (en) | 2015-02-09 | 2021-07-16 | 豪夫迈·罗氏有限公司 | Compounds for the treatment of cancer |
GB201502567D0 (en) | 2015-02-16 | 2015-04-01 | Sentinel Oncology Ltd | Pharmaceutical compounds |
CN107635984B (en) | 2015-03-11 | 2021-04-13 | Fmc公司 | Heterocyclic substituted bicyclic azoles as pesticidal agents |
GB201506933D0 (en) | 2015-04-23 | 2015-06-10 | Sentinel Oncology Ltd | Pharmaceutical compounds |
CN107635999B (en) | 2015-05-20 | 2020-09-25 | 豪夫迈·罗氏有限公司 | Compounds for the treatment of spinal muscular atrophy |
US10668171B2 (en) | 2015-05-30 | 2020-06-02 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
MA43072A (en) | 2015-07-22 | 2018-05-30 | Wave Life Sciences Ltd | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES |
US10226448B2 (en) * | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof |
TW201718546A (en) | 2015-10-02 | 2017-06-01 | 英塞特公司 | Heterocyclic compounds useful as PIM kinase inhibitors |
CN108137601A (en) | 2015-11-12 | 2018-06-08 | 豪夫迈·罗氏有限公司 | For treating the compound of amyotrophic lateral sclerosis |
CA3002494C (en) | 2015-11-12 | 2021-01-12 | F. Hoffmann-La Roche Ag | Compositions for treating spinal muscular atrophy |
US10383867B2 (en) | 2015-11-28 | 2019-08-20 | Russell Dahl | Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders |
CN108137579B (en) | 2015-12-10 | 2022-01-07 | 豪夫迈·罗氏有限公司 | Bridged piperidine derivatives |
WO2017100726A1 (en) * | 2015-12-10 | 2017-06-15 | Ptc Therapeutics, Inc. | Methods for treatng huntington's disease |
US10526345B2 (en) | 2016-04-08 | 2020-01-07 | Mankind Pharma Ltd. | Compounds as GPR119 agonists |
AR108325A1 (en) | 2016-04-27 | 2018-08-08 | Samumed Llc | ISOQUINOLIN-3-IL CARBOXAMIDS AND PREPARATION AND USE OF THE SAME |
MA45270A (en) | 2016-05-04 | 2017-11-09 | Wave Life Sciences Ltd | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES |
WO2017210134A1 (en) * | 2016-05-31 | 2017-12-07 | Board Of Regents, University Of Texas System | Heterocyclic inhibitors of ptpn11 |
WO2018022473A1 (en) | 2016-07-25 | 2018-02-01 | Wave Life Sciences Ltd. | Phasing |
TW201819386A (en) * | 2016-10-24 | 2018-06-01 | 美商傳達治療有限公司 | SHP2 phosphatase inhibitors and methods of use thereof |
WO2018187209A1 (en) | 2017-04-03 | 2018-10-11 | Acceleron Pharma Inc. | Compositions and methods for treating spinal muscular atrophy |
EP3630770A1 (en) * | 2017-05-26 | 2020-04-08 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors |
AU2018282154B2 (en) | 2017-06-05 | 2022-04-07 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
WO2019005980A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
AU2018309187C1 (en) | 2017-08-04 | 2023-09-07 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
WO2019165073A1 (en) | 2018-02-21 | 2019-08-29 | Relay Therapeutics, Inc. | Shp2 phosphatase inhibitors and methods of use thereof |
US20210069188A1 (en) * | 2018-03-21 | 2021-03-11 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof |
TW202003471A (en) | 2018-03-21 | 2020-01-16 | 美商傳達治療有限公司 | SHP2 phosphatase inhibitors and methods of use thereof |
SG11202009212WA (en) | 2018-03-27 | 2020-10-29 | Ptc Therapeutics Inc | Compounds for treating huntington's disease |
EP3814360A1 (en) | 2018-06-27 | 2021-05-05 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
KR20210042265A (en) | 2018-06-27 | 2021-04-19 | 피티씨 테라퓨틱스, 인크. | Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease |
SG11202012869SA (en) | 2018-06-27 | 2021-01-28 | Ptc Therapeutics Inc | Heteroaryl compounds for treating huntington's disease |
CN113840602A (en) | 2019-03-15 | 2021-12-24 | 斯基霍克疗法公司 | Compositions and methods for correcting aberrant splicing |
JP2022533120A (en) | 2019-05-13 | 2022-07-21 | ピーティーシー セラピューティクス, インコーポレイテッド | Compounds for treating Huntington's disease |
WO2021007378A1 (en) | 2019-07-11 | 2021-01-14 | Ptc Therapeutics, Inc. | Compounds for use in treating huntington's disease |
CN114650822A (en) | 2019-11-01 | 2022-06-21 | 诺华股份有限公司 | Use of splice modulators for treatment of slowing progression of huntington's disease |
CN115768762A (en) | 2020-04-09 | 2023-03-07 | Ptc医疗公司 | Compounds for the treatment of huntington's disease |
MX2023005541A (en) | 2020-11-12 | 2023-06-15 | Ptc Therapeutics Inc | Novel rna transcript. |
AU2022320725A1 (en) | 2021-07-30 | 2024-02-22 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
-
2019
- 2019-06-25 KR KR1020207036440A patent/KR20210042265A/en unknown
- 2019-06-25 CA CA3103976A patent/CA3103976A1/en active Pending
- 2019-06-25 PE PE2020002185A patent/PE20211378A1/en unknown
- 2019-06-25 AU AU2019294478A patent/AU2019294478B2/en active Active
- 2019-06-25 CN CN201980051041.4A patent/CN112654625A/en active Pending
- 2019-06-25 SG SG11202012674PA patent/SG11202012674PA/en unknown
- 2019-06-25 BR BR112020026545-4A patent/BR112020026545A2/en unknown
- 2019-06-25 JP JP2020572895A patent/JP7421507B2/en active Active
- 2019-06-25 EA EA202092896A patent/EA202092896A1/en unknown
- 2019-06-25 WO PCT/US2019/038889 patent/WO2020005873A1/en unknown
- 2019-06-25 MX MX2020014098A patent/MX2020014098A/en unknown
- 2019-06-25 US US17/254,660 patent/US11858941B2/en active Active
- 2019-06-25 EP EP19736566.1A patent/EP3814357B1/en active Active
- 2019-06-28 AR ARP190101808A patent/AR119651A1/en unknown
-
2020
- 2020-12-22 IL IL279688A patent/IL279688A/en unknown
- 2020-12-23 CL CL2020003378A patent/CL2020003378A1/en unknown
- 2020-12-24 CO CONC2020/0016285A patent/CO2020016285A2/en unknown
-
2021
- 2021-11-16 CL CL2021003022A patent/CL2021003022A1/en unknown
-
2022
- 2022-12-02 CL CL2022003434A patent/CL2022003434A1/en unknown
-
2023
- 2023-05-23 AU AU2023203241A patent/AU2023203241A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2020005873A5 (en) | ||
US10934302B1 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
JP2021503004A5 (en) | ||
JPWO2019191229A5 (en) | ||
JPWO2020005877A5 (en) | ||
AU2011240808B2 (en) | 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of JAK kinases | |
AU2021202398A1 (en) | Bicyclic lactams and methods of use thereof | |
DK2773638T3 (en) | HETEROARYLPYRIDON AND AZA PYRIDON COMPOUNDS AS INHIBITORS OF BTK ACTIVITY | |
KR20210005558A (en) | Huntington's Disease Treatment Compound | |
JP2017518326A5 (en) | ||
JP2020522570A5 (en) | ||
JP2014528482A5 (en) | ||
US20170145034A1 (en) | Alkynyl alcohols and methods of use | |
HRP20151232T1 (en) | 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6]nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor | |
JP2018527353A5 (en) | ||
CA3085937A1 (en) | Diazaindole compounds | |
JP2020526549A5 (en) | ||
JP2016525092A5 (en) | ||
JP2013523884A5 (en) | ||
JP2014506929A5 (en) | ||
RU2018112230A (en) | BICYCLE COMPOUNDS AS ATX INHIBITORS | |
JP2013522238A5 (en) | ||
JP2015537010A5 (en) | ||
JP2016507551A5 (en) | ||
RU2013136778A (en) | HISTONDESECETHYLASE INHIBITORS, COMPOSITIONS AND WAYS OF THEIR APPLICATION |